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INTRODUCTION 
Health is the chief basis for the development of the ethical, economic, 
artistic and spiritual sides of man .The wealth of a country depends not merely 
on its natural resources but also on the vitality of its people. 
“¤o°ßø©öŒÀÁ® ÂøÍÄ Cß£® H©® 
Aoö¯ß£|õmiØS CÆÁøÁ¢x”  
                                                                      & v¸USÓÒ 
 According to the theory of siddhars, the human body is composed of 
panjaboothas.The universe is also composed of the same.Human body is 
microcosmic, the universe is macrocosmic. 
AshzvÀ EÒÍ@u ¤sh®; ¤shzvÀ 
 EÒÍ@u Ash® 
Ash•® ¤sh•® Jß@Ó;  AÔ¢xuõß 
  £õºUS®@£õ@u. 
                                                                              & Œmh•Û bõÚ® 
 Human body is functioning with seven udalthathus and by rhythmic run of 
three uyirthathus. The alteration in uyirthathus leads to diseased condition. 
              Food plays a vital role in the rhythmic run of three uyirthathus. 
 “©¸¢öuÚ @ÁshõÁõ® ¯õUøPUS A¸¢v¯x 
  AØÓx @£õØÔ Eoß” 
                                                                                                                      & v¸USÓÒ 
            It says that a man who takes food after knowing the digestion of 
previous food, never needs to take medicine. 
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 One of the disease manifested by irregular diet is kalladaippu (Urolithiasis).  
Kalladaippu (Urolithiasis) or the formation of calculi  at any level of 
urinary tract is a common disorder as it has worldwide distribution.Particularly 
common in some geographic locations such as USA, South Africa, south east 
Asia. It is estimated that approximately 4% of world  population experience 
renal stone disease. 15% of indian population suffer from kidney stones. 
 Recurrent stone formation is a common part of the medical care of patients 
with stone disease.Calcium-containing stones, especially calcium oxalate 
monohydrade, calcium oxalate dihydrade and basic calcium phosphate are the 
most commonly occurring ones to an extent of 75-90% followed by 
magnesium ammonium phosphate (struvite) to an extent of 10-15%, uric acid 
3-10% and cysteine 0.5-1% (4-6). 
 Even though many siddhars explain about this disease, Yugi in 
hisyugivaidhyachindhamani elaborately described about its aetiology, 
pathology, classification, clinical features and prognosis of kalladaippu. 
 The diseases of urinary system are divided into two. They are 
 “}›øÚA¸UPÀ @|õ#” 
“}›øÚö£¸UPÀ @|õ#” 
 This disease kalladaippu comes under the classification of  “}›øÚA¸UPÀ 
@|õ#” 
 Which is producing low urinary output and driesup the urine and form urinary 
calculi due to various aetiological factors. The managerial professionals, 
sedentaryoccupationals are having higher incidents of kalladaippu than the 
manual workers. 
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 People who run to earn,forget to look after themselves,leads to loss of good 
health.In this stressful life when they  miss to drink water to flush out the waste 
product leads to calculi disease, kalladaippu. 
          In practice, many people were afraid of surgery and they like to take 
herbal medicines which are free from side effects. The patients who are 
recommended for surgery by urologists also brought stones after taking siddha 
medicines in our op. So that the author choose kalladaippu (urolithiasis) as 
her dissertation topic to find out a complete cure  without surgery. 
 For this, the author select Megarajangachooranam. Referred in 
Athmaratchaamirtham (Pa.no.430) to study its effect on kalladaippu 
pharmacologically, clinically.   
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AIM AND OBJECTIVES 
 AIM: The aim of my dissertation work is to evaluate the efficacy of the trial 
drug, Megarajangachooranam both clinically and experimentally in the 
treatment of kalladaippu. 
OBJECTIVES 
 To collect the authoric measures and literature reviews of 
kalladaippunoi in ancient siddha and modern literatures. 
 To have an idea of the incidence of the disease with regard to age, 
sex, occupation , socio economic status, food, climatic conditions 
and precipitating factors etc. 
 To expose the efficacy of siddhar’s diagnostic principles. 
 To utilize the possible methods to confirm the diagnosis and 
prognosis. 
 To have clinical trial on patients with kalladaippunoi with selected 
siddha medicine. 
¾ Megarajangachooranam (Athmaratchamirtham) 
 To evaluate  
                   Toxicological screening 
x Acute 
x Sub acute 
 Pharmacological screening 
x Lithotriptic 
 To find out the statistical analysis of clinical study. 
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REVIEW OF LITERATURES  
SIDDHA ASPECTS 
In siddha system, the disease Kalladaippu is mentioned by Yugi 
Munivar in Yugi vaidhya chinthamani 800. It is one of the Urinary diseases, 
which comes under Neerinai Arukkal Noi. 
“ePupUtpidf; Fzj;ij 
ePawptpj;Jf; brhy;th# 
ePupidg; bgUf;fbyhd;Bw 
ePupid aUf;f byhd;W  
ePupHpt[lBd bfhy;Yk; 
ePu;f;fl;L tpidfbshd;W” 
THERAN KARISAL 
SIDDHA MARUTHUVAM (POTHU) P.NO.460 
1.Verupeyar (Synonyms) 
 Atchmari  Rogam 
2.Eyal (Definiition) 
 Definition of Kalladaippu is mentioned in many Siddha Text Books.  Few of 
them are as  follows, 
 “jhbdd;w ‰j;jpuj;jpy; ewewbtd;W 
jA;fpBjhu; bghobaDk; kzy;jhdg;gh 
thbdd;w rpwpabjhU kzy;jhdg;gh 
tskhf te;J tpGk; Beha;f;Fj; jhBd 
        Vbdd;w m!;kup Buhfbkd;w Bguhk; 
vspjhff; fy;Yfs; jhd; tpGFk; BghJ 
Bfhbdd;w Fzof;fha; ‰j;jpuf;FÇyg;gh 
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Fzkhd ‰j;jpug;ig ePu;jhiu BfBs 
Bfslh Kd; Fwpapy; vupr;ry; fz;L 
bfhoahf Btjidfs; fhl;Lkg;gh 
thslh rpwpabjhU fw;fs; jhBd 
tskhd Kj;jpug;ig FHy; tHpg;ghahaj; 
Bjslh tUk;BghJ jpBufe;jd;dpy; 
bjupg;gJ Bghy apUBtjid bra;a[k;ghU 
ehslh fw;fs; jhdpwA;fp tpl;lhy; 
eykhd Btjidfs; jhd; jPUk; ghBu..” 
AGATHIYAR GUNAVAGADAM 
P.NO.296 
Agathiar says the definition of Kalladaippu as sand like crystals found 
in urine, followed by small size of stones  excreted in urine. Stones are 
stagnated in kidney, ureter, urinary bladder and urethra. Pain with burning 
sensation starts in urethral  orifice followed by agonizing pain when the stone 
moving in urethral tract from the bladder. The  pain is  relieved., when  the 
stone is removed or expelled. 
Large concentration of urine in the urinary bladder produces calculus or 
gravel. It causes difficulty in passing urine. 
According to Siddha Maruthuvam 
Sudden obstruction to the flow of urine, pain in the base of the penis in 
males and clitoris in females burning micturition, loin to groin pain, passing of 
small sand like stones along with urine are the cardinal features of this disease. 
According to Jeevaratchamirtham 
Kalladaippu is defined as pain in and around the umbilicus, fever, 
dysuria and urine smelling like that of goats urine. 
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NOI VARUM VAZHI (Aetiology) 
The causes of the disease in various siddha text books are, 
P»[QÚ@uõº uspºuõß Sizu@£ºUS® 
PÀö»¾®¦ ©°º©s uõß P»¢ußÚzvÀ 
A»[QÚ@uõµßÚ P»¢u¸¢u»õ¾® 
AÊP@»õk ‰zu £sh ©¸¢u»õ¾® 
©»[QÚ@uõº ©õ¨£sh ©¸¢u»õ¾® 
©¢uzvÀ Áõ#ÁõÚ £uõºzu¢ußøÚ 
x»[QÚ@uõº ¸]ußÛØ ”øÁzu»õ¾® 
”¸UPõ#U PÀ»øh¨¦ Á¢x @uõßÖ¢uõ@Ú   
 
bjspe;jBjhu; fy;yilg;g[ cw;gj;jp Bfsha; 
   rpwpJ ehl;blhlA;fpa Bkfe;jd;dpy; 
  jspe;Bjhu; ryg;igapYjpuj; Bjha;e;J 
   re;j rj;jhfBt gUj;Jf; bfhs;Sk; 
  tspe;jBjhu; thj gpj;j Bfhgpj;jf;fhy; 
   te;J bgU fy;yha; ePu;tHpailj;J 
  espe;j;;Bjhu; ehYtpjj; fy;yilg;g[ 
   ez;ghd tuyhW ehl;lf; BfBs. 
 YUGI VAITHYA CHINTHAMANI 
PAGE NO.283 
 This poem says, in chronic Mega noi (Syphilitic disease) the semen will 
stagnate for a long time, in the urinary tract, so it will obstruct the urine flow.  
The urine constituents will easily depoit on the urinary tract and form the stone, 
at that time by vitiation of Vatham and Pitham these small stone become larger 
in size and, block the urinary passage. Urinary stone are also formed due to the 
drinking of contaminated hard water, taking of food mixed with sand and small 
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stones, consuming of contaminated food articles, food containing more 
carbohydrate, unhealthy food habits etc. 
“FUjp khRwy; g[zu;r;rp kpFjy; 
    rpWeP ulf;fy; tpiuapy; mogly; 
    ePupae; jhf;fy; rpWeP ulf;fy; 
    tspBeha; kpFf;F Kzt[k; xGf;fk; 
    filg;gpoj; jpLjy; Bkf Kjw;gy 
    gpzpa[wy; vDkpit aog;gil ahff; 
    fy;yilg; bgd;DA; fLk;gpzp tpisa[k;.” 
SIDDHA MARUTHUVANGA SURUKKAM  
PAGE NO.142 
Derangement of humour in blood, Excessive indulgence in sexual 
activity or sexual perversion, Trauma on testes, Suppression of urine and 
semen. 
Inflammation of bladders, Syphilis (Mega noil), Stagnation of urine in 
urinary tract. Dryness of semen causes the formation of stones, Increased 
intake of food that, cause flatulence. 
There are 14 Natural urges in the body. The urine and seman are also the 
natural urges of our body.   So suppression of any one it causes fever, retention 
of urine which favours urinary calculi, chest pain, arthralgia, and white 
discharge. 
“ePupid jLj;jy; bra;apd; 
 ePu;f;fl;Lj; Jthuk; g[z;zhk; 
ghwpL re;J re;jpy; 
 gz;g[W BehtjhFk; 
BeupyA; faUk; fhkpak; 
 epr;ra Behjy; bra;a[k; 
ghupdpyghd tha[ 
 gz;g[wr; BrUkd;Bw” 
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“Rf;fpye; jida lf;fpd; 
 RuKl dPu;f;fl;lhFk; 
gf;fkh iffhy; re;J 
 ghuBeha; tHpapwA;Fk; 
kpf;fkhu; Beha[z;lhFk; 
 kpFe;jpLk; gpuBkfe;jhd; 
jf;fBjhu; BghJkhfpd; 
 jupj;jpLk;tha[f; TBw”. 
SIDDHA MARUTHUVANGA SURUKKAM  
PAGE NO.212 
   “miwfpBwd; tpe;jHpe;jhy; Bkfkhr;R 
   mKJ tHpe;J R{Lbfhz;lhy; tha[ BrUk; 
  giwfpBwd; R{iyFl;lk; fpue;jpg; g[w;W 
   gt[j;jpu fs;gpsit Bghl;L fz;lkhiy 
  miwfpBwd; miuahg;g[ xl;oa g[$ 
   mUA;fug;ghd; rpuA;F Fd;kk; khePu;f;fl;L 
  FiwaBt ePu;bfhz;l me;Beha; fhrk; 
 Foykhk; BgjpBahL fpuhzp ghz;Bl”. 
- Agathiyar vaithiya vallathy 600. 
- PAGE No.175 
The above poem describes that, when the semen is destroyed by body 
heat. Vatham will add with that, and many diseases will come, including 
Kalladaippu. 
POTHU KURI KUNANGAL (General Signs & Symptoms) 
Gradual or sudden obstruction to flow of urine, Unbearable pain 
(agonizing pain) in the penis, Excruciating pain  and swelling is experienced at 
tip of penis if the calculus attempts to expel, Colicky pain radiating from loin to 
groin, lower abdomen urethra and genitalia, if the calculus is irregular with 
sharp projection it produce burning and scanty micturation with haematuria. 
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SYNDROMES ASSOCIATED WITH KALLADAIPPU 
    cf;fhur;R{iy 
“Fj;JKf; fhur{iyapd; Fze;jhd; 
 Bfhu;itaha; tpyhtjdpy; KJfpy; beq;rpy; 
mj;jpapdpy; ehgpapy ghdkhA; Fjj;jpy; 
 mjpfj;Jd; khA;fpre;jhd; tsu;e;J Bktpg; 
gj;Jkze; gLf;ifBghw; ryj;J thug; 
 gjpbeUA;fp K}j;jpukhA; fpupr;rp a[z;lha;j; 
jr;RrlA; fLg;bgLj;J kjpf yA;fpj; 
 jsu;r;rpbahL kaf;fkhfj; js;Se;jhBd”. 
- SIDDHA MARUTHUVAM  
- PAGE NO.325 
Excessive growth of muscles in chest region, back of trunk, umbilicus 
and anal urethral orifice followed by stricture of urethral orifice like a sand like 
crystals blocked in urethra. Dysuria, body pain, impairment of conscious, 
tiredness and giddiness occurs. 
5.    CLASSIFICATION 
 In Siddha system, various types of kalladaippu are mentioned in various text 
books of Siddhars. 
Bjhd;wplBjhu; ehypdpl ehkA;Bfsha; 
RWf;fhd thjj;jpd; fy;yig;g[ 
g{d;wpaBjhu; gpj;jj;jpd; fy;yilg;g[ 
g[uz;lBjhu;  rpByl;Lkj;jpd; fy;yilg;g[ 
jd;dpaBjhu; brhe;jkh fy;yilg;g[ 
Bjfj;ijg; gw;wpBa rpwpJ fhyk; 
jhd;wpBa ryg;igapy; te;jHpe;J 
fUtpBa ypA;fj;jpw;wupf;Fe; jhBd. 
Yugi vaithya chindamani 
PAGE NO.248 
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As per Yugi vaithya chindamani  
1. Vali Kalladaippu 
2. Azhal Kalldaippu 
3. Iya kalladaippu 
4. Mukkutra kalladaippu 
SIGNS AND SYMPTOMS OF ABOVE CLASSIFICATION ARE 
1.Vali Kalladaippu 
 “jupj;J ehgpf;FA; fPH;R;Ruf;fha; Fj;jpr; 
  ry kye;jhd; tPHhkw;wk;gkhfp 
  tupj;Jk ypA;fj;jpy; typa[khfp 
  kUtpaBjhu; bghj;jpbay;yh Rue;Jfl;o 
  jpupj;jpBa fplf;bfhlha; g[ul;lyhfpj 
  Bjk;gpBa K}r;Rkha; tapW Kg;g[k; 
  cupj;jBjhu; rijBghy; ctu;g;g[khFk; 
  XA;FfpaBjh thjf; fy;yilg;g[jhBd”. 
Yugi viathya chindamani 729 
PAGE NO.284 
 Acute pricking pain in the lower abdomen, scanty urination, obstruction to the 
flow of urine, pain in the penis making the patient unable to sit. Patient will 
cry, swelling in the abdomen, Albuminuria will be present with mucous 
discharge and black coloured stone will be expelled. 
2.Azhal Kalladaippu 
  “milg;ghfpr; rye;jhD kUtyhfp 
  maA;fha;r;rpr; brhUfpdhw; BghByfhDk; 
  g[ilg;ghfg; bghj;jpbaA;Fk; g[Gf;fkhfpg; 
  g{l;Lg;Bghy; tpFthfpg; gpul;lyhFk; 
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  kilg;ghfp cjpuepwkha;f; fy;yhfp 
  te;jpHe;J ypA;fj;jpy; khl;of; bfhs;Sk; 
Filg;ghfp Fw;wyha;f; Tr;ryhfpf; 
 Fjl;LBk gpj;jf; fy;yilg;g[j;jhBd”. 
Yugi vaithya chindamani 73 
PAGE NO. 285 
Obstruction to the flow of urine, burning sensation in the external 
meatus, acute pain in the urethra and excretion of small red coloured stones. 
3.  Iyya Kalladiappu  
 “jhdhd bjhg;g[spBy tpy;Yg; Bghyr; 
 rypakhw; Rue;JBk rw;Bw Fj;Jk; 
 Vdhd fhbyhL iffs; re;J 
 nLg;g[ jhd; Filr;ryh aprpt[ fhZk; 
 Btdhd ypA;fj;jpd; Btz;ik jd;dpd; 
 tpWtpbwd;Bw fLg;ghfp tpau;itahFk; 
 Bjdhd btWg;gf;fy; rpWfy;yhfr; 
 Rpf;fyha; te;jpwA;F rpByl;Lke;jhBd”. 
Yugi vaithya chindamani 731 
PAGE NO. 285 
In this type of kalladaippu the symptoms are severe pain in the umbilicus, pain 
radiating towards thigh, pain in the joints, burning micturition, excessive 
sweating, small white coloured stones will come along with the urine. 
4.Mukkutra Kalladaippu  
 “te;jpwA;Fk; ePu;j;jhiuao apw;whDk; 
 khtUj;j Kz;lhfp typa[khfp 
  behe;jpwA;fp ePu;jhD kUtpg;gha[k; 
  beha;jhd rpWkzw; Bghy; behWA;fpf;fy;yhk; 
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  re;jpwA;fp ePu; tHpapy; te;J tpGk; 
  jhf;fhd rpwA;liff;fy; jpdbkhd;Wf;F 
  bjhe;jkhA; fy;yilg;g[r; R{l;ol;lhBa”. 
Yugi vaithya chindamani 
PAGE NO.286 
Severe pain in Urethra, Dysuria, Oliguria, Crystals excreted in urine in 
the form of small sands, Handful crystals excreted in urine. It is a fatal disease. 
The other name of Mukkutra kalladaippu is Venneer kalladaippu or 
Manar kalladaippu. It is mentioned in Aruvai Maruthuvam. 
In Siddhar Aruvai Maruthuvam : 
PAGE NO.112 
1. Vali kalladaippu 
2. Azhal kalladaippu 
3. Iya kalladaippu 
4. Venneer or Manar Kalladaippu 
Classification According to Noi  Vilakkam 
 “tspKjy; ‰d;wpD Bjhd;wyhYk; 
 fUePu; jd;dpw; Bjhd;wyhYk; 
fy;yil ehy;tifg; gLbkd bkhHpBa” 
There are 4 types of Kalladaippu according to Noi vilakkam 
 
1. Vali Kalladaippu 
2. Analaka kalladaippu 
3. Iyya Kalladaippu  
4. Karuneer Kalladaippu  
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tspf;fy;yilf; Fwpfs; 
“glu;kpfg; gLjy; gw;fs; foj;jy; 
eLA;fy; ce;jpa[A; Fwpa[k; gpirjy;  
frLfPH; tspbahL fHyy; mGjy;  
rpWePu; Jspj;jy; vd;gt[k; gpwt[k; 
tspapd; fy;yilf; Fwpbad bkhHpg. 
(glu; Beht[ Jd;gk; - kyk; tsp – thjk;) 
fWj;jq; rpte;Jk; Kisfs; gue;Jk; 
tspapd; fy;yJ tot[W bkd;g". 
Tongue Biting Palpitation and Shivering, Crushing pain of the lower 
abdomen and genital organ, drippling of urine, the stones are blackish red in 
colour. 
 mdyf; fy;yilf;Fwpfs; 
“Rl;bld ePupak; kpfbtk; gpLjYk; 
BehjYk; mdiyf; fy;yilf; FwpBa 
Rpte;JA; fWj;J kq;r shfpa[k; 
BrA;FU totpy; fy;yJ Bjhd;Wk; 
(Bjhd;Wk; vd;gijf; jdpj;jdpf; Tl;Lf)” 
Burning Micturation, Dysuria, The stones are reddish black or yellow 
in colour and  small in size. 
Iaf;fy;yilf;Fwpfs; 
“ePupaA; Fj;jy; jpzpj;jy; Fspu;jy; 
vDkpit Iaf; fy;yilf;FwpBa 
btSj;Jk; Bjdpw khfpa[ bkhspu;e;Jk; 
bgUto t[ilj;jhk; Iaf; fy;yil” 
Pricking pain, forceful pain with severe intensity when passing urine, 
Fever with rigor, White or honey coloured shining or luminant larger size 
stone expelled. 
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fUePu;f;fy;yilf;Fwpfs; 
“fUeP ul;ffypd; tsprpde;bjGe;J 
tpiudsp dLtpy; mJjidj; jLj;jypd; 
fUePu;f; fy;yil kUtpL bkd;g”. 
 Increased  vatham, preventing ejection of semen. 
MUKKUTRA VAERUPADUGAL :( Pathogenesis) 
Disease occurs due to the derangement in 
x     Uyir thathukkal  
x Udalthathukkal   
x Kaalamaarupaadu (seasonal changes) 
x Thinai( living lands ) and 
x Udal vanmai. 
 
Mukkutra Iyal : 
The function of the three uyir thathus:  
a) Vali   –  (Kattru + Veli) 
b) Azhal   – (Thee) 
c) Iyyam   – (Neer+Mann) 
 The alteration of three thathu in their reaction to extrinsic or intrinsic factors 
results in disharmony. This altered harmony and balance variation of the three 
thathus results in disease. Their natural ratio (1 :½:¼) to each other is discerned 
by the physician at the wrist and each nadi is individually assessed for its 
strength, speed and regularity. 
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VATHAM 
  The term vatham denotes vayu, dryness, pain and flatulence. Based on 
functions and locations it is classified in to 10types. They are tabulated below. 
 S. 
No Vatham General Features 
Changes in 
Kalladaippu 
1. Piranan  Responsible for respiration 
and it is necessary for proper 
digestion  
Normal 
2. Abanan Responsible for  all downward 
forces such as voiding of 
urine, stools, semen, 
menstrual flow  
Affected  
(scanty 
micturition) 
3. Viyanan 
(paravukaal) 
Dwells in the skin and is 
concerned with the sense of 
touch... extension and flexion 
of the parts of the body and 
distribution, of the nutrients to 
various parts of the body 
   
Normal 
 
 
 
4. Uthanan 
(melnokkukaal) 
Responsible for all kinds of 
upward motion such as 
nausea, vomiting etc... 
Affected 
(nausea, 
vomiting) 
5. Samanan 
(nadukkaal) 
Considered essential for 
proper digestion, assimilation 
and carries the digested 
nutrients to each and every 
organ 
Normal 
6. Nagan  Helps in opening &closing of 
eyelids 
Normal 
7. Koorman  Responsible for vision, 
lacrimation  and yawning 
Normal 
8. Kirugaran Induces  appetite, salivation, 
all secretions in the body 
including nasal secretion and 
sneezing 
Normal 
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 S. 
No Vatham General Features 
Changes in 
Kalladaippu 
9. Thevathathan  Induces and stimulates a 
person to become alert, get 
anger, to quarrel, to sleep etc 
Normal 
10. Dhananjeyan  Resides in the cranium and 
produces bloating of the body 
after death. This leaves from 
the body after 3days of death, 
forming a way through the 
skull. 
Normal 
 
PITHAM 
It is the thermal life force of the body. It is subdivided into five types. They are 
S. No Pitham Normal Features Changes In Kalladaippu 
1. Anarpitham  Peps up the appetite and aids 
in digestion. 
Normal  
2. Ranjagapitham  Responsible for the colour 
and contents of blood. 
Normal  
3. Saathagapitham Controls the whole body and 
is held responsible for 
fulfilling a purpose. 
Affected 
(dysuria,oliguria) 
4. Pirasagapitham  Dwells in the skin and 
concerned with the shine, 
glow, texture and its 
complexion 
Normal 
5. Alosagapitham  Responsible for the 
perception of vision. 
Normal 
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KABHAM 
It is responsible for the stream lined functions of the body and 
maintains body’s defence mechanism intact. It is again classified into 5 types. 
S. No Kabham General Features Changes In Kalladaippu 
1. Avalambagam  Lies in the respiratory organs, 
exercises authority over other 
khapas and controls the heart and 
circulatory system. 
Normal 
2. Kilethagam  Found in stomach as its seat, 
moistens the food, softens and helps 
to be digested. 
Normal 
3. Pothagam  Hold responsible for the sensory 
perception of teste. 
Normal 
4. Tharpagam  Presents in the head and is 
responsible for the coolness of the 
eyes, sometimes may be referred to 
as cerebrospinal fluid 
Normal 
5. Santhigam  Necessary for the lubrication and the 
free movements of joints. 
Normal 
 
PARUVAKALAM   
S.  
No Perum Pozhuthugal Mukkuttra Marupaadugal 
1. Kaar kaalam 
(Aavani & purattasi) 
Aug 16 to Oct15 
VATHAM-vettunilai vazharchi 
PITHAM-thanilai vazharchi 
2. Koothir kaalam 
(Iypasi &karthigai) 
Oct 16 to  Dec15 
VATHAM- thanilai vazharchi 
PITHAM- vettunilai vazharchi 
3. Munpani kaalam 
(Margazhi & Thai) 
Dec16 to Feb15 
PITHAM- thanilai vazharchi 
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S.  
No Perum Pozhuthugal Mukkuttra Marupaadugal 
4. Pinpani kaalam 
(Masi& Panguni) 
Feb16 to June15 
KABHAM- thanilai vazharchi 
5. Elavenir kaalam 
(chithirai & vaikaasi) 
April16 to June15 
KABHAM- vettunilai vazharchi 
6. Mudhuvenir kaalam 
Aani & AadiJune16 to Aug15 
VATHAM- thanilai vazharchi 
 
THINAI (LAND) 
            Siddhars classified the lands in to five types. They are 
1. Kurunchi   - Mountain range 
2. Mullai          - Pastoral area of the forest 
3. Marudham  - The fertile river bed 
4. Neidhal       - The coastal region 
5. Paalai          - Arid desert                                                                     
x The winter season gives good health to the man, early summer and latter 
rainy gives moderate health. Whereas early rainy and latter summer are 
more prone to diseases, that’s why siddhars called it as Aanaga kalam 
Marudha nilam is the fertile area where no disease occurs 
  
20 
 
RELATION BETWEEN MUKKUTRAM, KAALANGAL AND 
THINAIGAL 
Mukkutram 
Paruvakalam (Seasons) 
Thinai Thannilai 
vazharchi 
(Accumulation) 
Vaetrunilai 
vazharchi        
(Aggravation) 
Thannilai 
adaithal             
(Alleviation) 
VATHAM Muthuvenil 
Kalam 
Kaar kalam Koothir kalam Vatha disease is 
more prevalent 
in neidhal land 
PITHAM Kaarkalam Koothir kalam Munpani Pitha disease is 
more prevalent 
in mullai land. 
KAPAM pinpani Elavenil kalam Mudhuvenil 
kalam 
Kapha disease 
is more 
prevalent in 
kurinchi land 
 
UDAL VANMAI (IMMUNITY): 
            Siddhars classify Udal vanmai as three types. They are 
1. Iyarkai vanmai 
2. Kala vanmai 
3. Seyarkai vanmai 
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UDAL KATTUGAL 
S. 
No Udal Kattugal General Features 
Changes In 
Kalladaippu 
1. Saaram 
(digestive essence) 
Responsible for the growth& 
development. It keeps the 
individual in good temperament 
and it enriches the bood. 
Affected due to 
pain 
2. Senneer (blood) Responsible for the colour of 
blood and for the intellect, 
nourishment, strength, vigour 
and valour of the body.  
Normal 
3. Oon (muscle) Gives lookable contour to the 
body as needed for the physical 
activity. It feed the fat next day 
and gives a sort of plumpness to 
the body  
Normal 
4. Kozhuppu (fat) Lubricates the organs to 
facilitate frictionless functions. 
Normal 
5. Enbu (bones) Supports & protects the vital 
organs, gives the definite 
structure of the body and 
responsible for the posture and 
movements of the body 
Normal 
6. Moolai (bone 
marrow) 
Nourishes the bone marrow and 
brain which is the centre that 
controls other systems of body 
Normal 
7. Sukkilam/ 
Suronitham(sperm/ 
ova) 
Responsible for reproduction Normal 
 
PINIYARI MURAIMAI (DIAGNOSIS) 
Four steps are followed in diagnosing the disease. They are, 
a. Poriyaal arithal 
b. Pulanal therthal 
c. Vinaathal 
d. Envagaithervu  
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In detail, 
a.Poriyaal arithal 
 In this the physician should carefully observe the changes that occur in the five 
sensory organs (Porigal) of the patient. 
b.Pulanal therthal 
 The physician carefully applies his five senses of perception, smell, taste, 
vision, touch and sound to understand the condition of the patient. 
c.Vinaadhal 
 The physician should interrogate about the patients name, age, occupation, 
socio economic status, food habits, history of past illness, history of present 
illness, family history, marital status, menstrual history and frequency of pain. 
d.ENVAGAI THERVUGAL 
eh epwk; nkhop tpop ky%j;jpuk; 
ehb guprkpit kUj;JtuhAjk;” 
-Neha;ehly; Neha; Kjdhly;-253 
 Nowadays advanced diagnostic tools have been developed by modern bio-
medical scientists. But Siddhars have given eight diagnostic methodological 
tools. They are called as Envagai thervu. 
Eight fold system of clinical assessments 
Siddhars have given eight diagnostic methodological tools. They are, 
1. Naa 
2. Niram 
3. Mozhi 
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4. Vizhi 
5. Malam 
6. Moothiram 
7. Naadi 
8. Parisam 
GENERAL FINDINGS 
1.NAA 
Signs and symptoms in the tongue are noted here. 
Color, salivary secretion, ulcers, coating, inflammation, taste changes, 
deviation and its nature are generally noted. 
   In kalladaippu the naa  not affected. 
2.NIRAM 
 The color of the skin is noted here. 
          In kalladaippu the niram may be affected in sukkila atchmari. 
3.  MOZHI 
 Character of the speech is noted, mainly uratha oli (high pitched), 
thazhntha olli(low pitched), or resembles the sound of any instrument. 
 In kalladaippu the mozhi will be affected to the patients who have severe 
pain leading to the thazhntha olli 
4.VIZHI 
 Character of the eye is noted. Color, warm, burning sensation, irritation, 
visual Perception.   
 In kalladaippu the vizhi may be affected redness due to renal colic pain. 
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5.MALAM  
 The stools are examined for quantity; hardening (malakattu), loose 
motion (bethi), Color and smell. 
 In kalladaippu the malam will be affected due to either constipation or 
diarrhea. 
6.MOOTHIRAM 
a.Neerkuri 
  The urine is examined for its color, odour, volume, froth and weight. 
  In kalladaippu  the moothiram is affected due to scanty micturation. 
b.NEIKURI 
mUe;J khwp ujKk; mtpNuhjkjha;  
mf;fy; myu;jy;mfhyt+d; jtpu;jow; 
Fw;wstUe;jp cwq;fp itfiw 
Mbf;fyrj; jhtpNa fhJnga; 
njhUK$u;j;jf; fiyf;Fl;gL }upd; 
epwf;Fwp nea;Fwp epUkpj;jy; flNd” 
                    -rpj;j kUj;Jthq;fr; RUf;fk;  gf;fk;509  
The early morning urine of the patient is analyzed by dropping a drop of 
gingely oil on the surface of the urine sample. The accumulation, formations, 
changes, and dispersal under the sunlight without any external disturbances of 
the urine sample can be noted.  
x Vatha neer - The oil spreads like snake 
x Pitha neer - The oil spreads like ring 
x Kapha neer - The oil spreads like pearl 
x If the oil spreads gradually, it indicates good prognosis 
x If the oil spreads fast or gets mixed completely with urine or sinks in 
urine, it suggests bad prognosis. 
Since kalladaippu is due to the derangement of vatham and pitham,the 
neikuri will be vatha or pitha neer. 
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7.NAADI 
 Naadi is responsible for the existence of life can be felt one inch below the 
wrist on the radial side by means of palpation with tips of index, middle and 
ring finger, corresponding to Vatham, Pitham, Kapam. 
 Three humors Vatham, Pitham, Kapam existing the ratio 1:½:¼  normally. 
Dearrangement in these ratio leads to various disease conditions. 
Naadi nadai in Kalladaippu  
 “tpGFk; rpyBeuk; tpLgl;L ePBuhLk; 
  xGfpa tha[t[k; xJA;fpdhy; BehfhJ 
  tGfpa ke;jj;jhy; tha[te;Bj g[fpy; 
  fGkp Kjpu;e;jpLk; fy;byupg;g[ MFBk”. 
Thirumoolar karukadai vaidhyam 
Page No.180 
 
 When the vatham add with mantham it produces the kalladaippu disease, 
Raththinachurakkam Naadi also describes aggravation of vatham produces the 
symptoms of Kalladaippu. 
 “Vtyha; FGyha; gpj;jq; bra;Fzk; tpsk;gf;Bfsha; 
BfhyBty; tpHp rpte;J Fspu;e;jpoUf;F ky;yhy; 
rPyBt ePu;fLj;J behe;J RWf;bfdr;R te;J tpGk; 
qhyBk fpWfpbwd;W eht[yu;e;jpUf;fA; fhBz”. 
Siddha maruthuva noi naadal noi mudhal naadal thirattu. 
Page No.168. 
 It described aggravated pitham will produces the symptoms of Kalladaippu. 
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!;guprk;:  (Touch) 
8.SPARISAM  
 By sparism the temperature of skin (thatpam – cold or veppam – heat) 
smoothness, roughness, sweating, dryness, hard patches, swelling, abnormal 
growth of organs and tenderness can be felt. 
 In Kalladaippu patients tenderness over the lower abdomen, renal angle and 
lumbar region. 
 Also patient’s temperature is increased in lower abdomen sweating all over the 
body at the time of colic. 
ePu;f;Fwp (Urine examination) 
 Urinary examination is good diagnosis method compare to naadi and other 
Envagai thervugal. Thereiyar mention below as 
ePu;f;Fwpr;rpwg;g[ 
“ju;f;frhj; jpupf shBdhu;  
 jA;fspw; Bwu;e;J eho 
tu;f;fkhk; eho jd;dpy; 
tUtJ kaf;f bkd;Bw 
cw;wePu;g; gupl;ir aha;e;Bj 
 a[iuj;jd upjw;F Beuha; 
kw;bwhU tpjpE ypy;iy 
 kUj;Jtf; fiyty;Byhu;f;Bf”. 
Theriyar Neekuri Neikuri Nool 
Siddha maruthvanga surukkam 
Page No.372 
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“mUe;JkhupjKk; mtpBuhjkha; 
m|fy; myu;jy; mfhyt{z; jtpu;e;jHw; 
Fw;wstUe;;jp cwA;fp itfiw 
Mof;fyrj; jhtpBafhJ bga; 
bjhU KFu;j;jf; fiyf;Fl;gL ePupd; 
epwf;Fwp bea;Fwp epUgpj;jy; flBd”. 
Theriyar Neekuri Neikuri Nool 
Siddha maruthvanga surukkam 
Page No.334 
 Siruneer Should be collected in early morning ; patient should be eating six 
tastes of food with  regular time and well sleeping over night, urine should be 
examine with in 3% hours. 
Siruneerin pothugunam 
 “te;j ePu;f;fup vil kzk; Eiu vq;rbyd 
  iwe;jpaYsit aiwFJ KiwBa” 
Theraiyar Neerkuri Neikuri Nool 
Siddha maruthuvanga surukkam 
Page No. 297 
1. Niram (colour) 2.Eadai (Specific gravity) 3. Nurai (Froth) 4. Natram 
(Smell) 5.Enjal (Deposits) 
 Above the five parameters by which each urine sample should be examined. 
NIRAM (COLOUR) 
NIRA THOGAI 
“gPjk; brk;ikigA; fUik btz;ikbad; 
 BwhijA; bfhGikia bahj;JF ePBu” 
Theraiyar Neerkuri Neikuri Nool 
Siddha maruthuvanga surukkam 
Page No. 298 
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1. Yellow 
2. Red 
3. Green 
4. Black 
5. White 
Urine may be any colour mention above 
fy;yilg;g[ ePupd; Fzk; ( COLOUR INDICATING URINARY STONES) 
 The urine colour would look like flesh washing water this is indicated in 
kidney diseases. 
“jPg;g[yhy; fGePu;r; brabydpu; Fz;of; 
fha;j;Ju;g; gyj;jhy; fjpj;j ePuhkj; 
Ju;g;gyf; fgKk; Brhupa[k; bfhjpg;g[wg; 
gw;gfyhfg; igag; gjpe;Bj”. 
Theraiyar Neerkuri Neikuri Nool 
Siddha maruthuvanga surukkam 
Page No. 341 
EADAI (SPECIFIC GRAVITY) 
 Urine not thick is considered healthy. 
“kpfj; jog;g[k; kpfj; BjwYk; nd;bwdpy; 
Rfj;ijj; jUk; bka;r; Rght ePu; ed;bw”. 
Theraiyar Neerkuri Neikuri Nool 
Siddha maruthuvanga surukkam 
Page No. 344 
NURAI (FROTH) 
 “ge;jbka;g; girapsfg;gLk; gUtj; 
 je;ju;g; g{jkha; mdpy K}j;jpuj;jpy; 
 rk;ge;jg;gLk; jjpEiug; g[dBy”. 
Theraiyar Neerkuri Neikuri Nool 
Siddha maruthuvanga surukkam 
Page No. 346 
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 Urine may be frothy in nature, if it is reduced in vali, azhal and ayyam are said 
to be deranged. 
NAATRAM (SMELL) 
kztpyf;fzk; 
 “Xjkzj;Bjh ltBthj bkhj;jp wA;Fk; 
  rPjsq; fk;kpa BjfpfSf;Bf 
 fhzpjpy rPGw; fye;jpHp kzKwpd; 
  fUg;geh gpfSSA; fhkeh sj;JSk; 
 tpuzKz; od;Bwy; va;J kRkupay; 
  jpUj;jBy jpz;z bkdkdj; Jd;Bd”. 
 Theraiyar Neerkuri Neikuri Nool 
Siddha maruthuvanga surukkam Page No. 345 
 
 Foul odour with pyuria is observed in patients with urinary lithiasis associated 
with urinary tract infection and ulcer. 
ENJAL (DEPOSITS) 
 If urine excretion look like cured water white colour and sand like deposits in 
urine indicate stones in kidney. This mention as  
“ehu;j;jp ePu;g;ghy; Bghy 
edt[w;wA; fpHpa[ khdhy; 
khuw;g Kw;w ePup 
yo kz;of; fple;j jhdhy; 
ghupe;j bkGF khA;fha; 
gw;wpa fy;tp dhBy 
rPUw;w bra;if bad;W 
bjupt[wr; brg;g yhBk”. 
- rpj;j kUj;Jtha;fr; RUf;fk;  
Page No.575 
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NEI KURI 
 The urine kept on the kidney tray in sun light, on non wind condition, should 
be examined by dropping a drop of gingili oil gently with rod. If oil spread like 
snake, it indicates valineer, a ring indicates azhal neer, and float like a pearl it 
indicates iyya neer and sinks in urine indicates mukkutram.  
 “mubtd ePz;od|Bj thjk; 
  MHp Bghw; gutpd; m|Bj gpj;jk; 
  Kj;bjhj;J epw;fpd; bkhHptbjd; fgBk”. 
- rpj;j kUj;JthA;fr; RUf;fk;    
Page No.532 
 In Kalladaippu patients, oil spreading like ring indicates Azhal neer or snake 
indicates Vali neer. 
NOI  KANIPPU  VIVAADHAM 
(Differential diagnosis of  kalladaippu 
1. }µøh¨¦ 
2. }ºUPmk 
3. }ºa”¸US 
rhj;jpak;, mrhj;jpak; (PROGNOSIS) 
 “rpl;oarhj; jpaj;jr; brhy;yf; Bfsha; 
  RSf;fhFk; thjj;jpd; fy;yilg;g[ 
 g{l;ol;l gpj;jj;jpd; fy;yilg;g[g; 
  g[fHhdBrl;Lkj;jpd; fy;yilg;g[ 
 Kl;ol;l nJK}d;Wk; rhj;jpakhfp 
  Kidahd kUe;Jfspw; brk;ik ahFk; 
 Bjhl;ol;l bjhe;jkhA; fy;y ilg;g[j; 
  bjhLRWBt bfhy;YkpJ R{l;re; jhBd”. 
 Yugi Vaidhya Chintamani 
Page No.225 
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 According to Yugimunivar, vali, Azhal, and Ayya Kalladaippu are curable 
where as Mukkutra Kalladaippu is incurable. 
kUj;Jtk;  (LINE OF TREATMENT) 
 The entire siddha system of medicine consists of three great subdivisions 
namely, 
1) Noyillaneri   (preventive)  – Kaappu 
2) Noineekkuneri   (curative methods)  – Neekkam 
3) Uramaakkumurai   (strengthening methods)  - Niraippu 
 Noyillaneri is the special approach of the siddha system where regular dietary 
habits , early rising , physical and mental discipilinaries are all emphasized. 
Prevention can mostly save our body and soul, but modernization results in 
alteration of good health, leads to disease, 
 Siddha system is playing major role in treating and preventing many chronic 
diseases. Like wise , Herbal medicines have several phyto chemicals which 
exert their beneficial effect on urolithiasis by multiple mechanisms like, 
x Diuretic activity 
x Crystallisation inhibiting activity 
x Lithotriptic activity 
x Antimicrobial activity 
x Analgesic and anti inflammatory activity 
x Improving renal function 
x Regulates oxalate , Calcium mechanisms. 
 The main object of treatment is to bring down the deranged mukkutrams 
to natural equilibrium by giving purgatives, which cure derangement of 
vatham, this one of the cause for Kalladaippu. 
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 As per the above mention, author gives purgation to all patients as their 
body condition, the author of dissertation has selected trial drug Agasthiar 
kulambu 50mg with Rice water empty stomach oneday only. 
 In Siddha sytem treatment is not only removable of disease but  also the 
prevention and improving the body condition after removal of disease. This is 
said as kappu, neekkam and niraippu. 
Fomentation  
 An attack of renal colic may be aborted by the application of heat 
fomentation (hot water bottle or heater) to the lumber region Immediate 
treatment of loin pain or renal colic is bed rest. 
Prevention 
1. For prophylactic purpose it is necessary to eliminate all hindrances to a 
free drainage of urine (constricition, adenoma of the prostrate etc) and to 
remove foci of infection from the teeth and tonsils. 
2. To prevent the formation of urate calculi a diet of milk and vegetables 
and mineral water is prescribed. 
3. In the presence of oxalate calculi restrictions are imposed on foods rich 
in calcium (Milk, raw eggs, potatoes) with total abstinence from 
chocolate, spinach gooseberries and carrots. 
4. A patient with phosphorus, carbonate stones is kept on a meat diet and 
much water to drink. 
Advice 
1.Patients should drink large amount of water (4 lit / day) 
2.Patient should not suppress the excretion of urine and seminal fluid. 
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3.         Preparation containing Vit. D.Must be avoided. 
4. Regarding prevention Anubhava vaidhya deva ragasiyam states that one 
should not suppress the excretion of Moothiram (Urine) and Sukkilam 
(Seminal fluid) 
DIET FOR KALLADAIPPU PATIENTS 
Do’s 
1. Drink 2-3 times of water daily. 
2. Drink lemon juice, grape, sugarcane, cucumber juice with seeds 
melon juice, tendercoconut, barely water, plaintain pith juices. 
3. Eat the following vegetables and Greens. 
1. Raddish 
2. Ladysfinger 
3. Bottle guard 
4. Onion 
5. Sirukeerai 
6. Pasalai keerai 
7. Keeraithandu 
8. Coriander leaves 
9. Mint leaves 
Dont’s 
1. Avoid drinking fluoride containing water 
2. Aviod Milk & its products, Fish and other seafoods. 
3. Aviod cabbage, cauliflower, tomato seeds, mushroom. 
 
 
34 
 
MODERN ASPECTS 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM 
KIDNEY 
 Kidneys are a pair of excretory organs situated on posterior abdominal wall,  
One on each side of the vertebral column behind the peritoneum. These organs 
are responsible for removing excess water, salt and waste products from the 
blood for maintaining its PH. 
Location 
 The kidney is occupying the epigastric, hypochondrium, lumbar and umbilical 
regions. Vertically they extends from the upper border of  T12 Vertebra to the 
centre of the body of L3 vertebra. 
 The Right kidney is slightly lower than the left kidney. And the left kidney is 
little nearer to the median plane than the right. The transpyloric plane through 
the upper part of the Hilum of Right kidney and the lower part of the hilum of  
Left kidney. 
Size, Shape, Measurement 
 Each kidney is Bean shaped it is 11cm length 6 cm breadth, 3 cm thickness. 
Weight of the kidney is 150gm in males, 135 gm in females. 
 The Left kidney in little longer and narrower than the Right kidney because the 
long axis of kidney is directed downwards and laterally. So that the upper poles 
are nearer to the medium plan. 
External features  
 Kidney are reddish brown in colour. Each kidneys has following features. It 
has 2 poles (upper and lower), 2 borders (medial and lateral), 2 surfaces 
(anterior and posterior). 
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 The upper poles are broad because they are compressed by corresponding 
supra renal glands, Lower poles are narrow 
 Lateral borders are convex and medical borders are concave with hilum in the 
middle. Anterior surface is some what irregular and posterior surface is flat. 
Capsules of kidney  
1. Fibrous capsule: This is a thin membrane which closely invests the 
kidney and lines the renal sinus. 
2. Perirenal fat: This is layer of adipose tissue lying outside the fibrous 
capsule. It is thickest at the borders of the kidney and fills up the extra 
space in the renal sinus. 
3. Renal fascia: This is a fibro aerolar sheath which surrounds the kidney 
and periorenal fat. 
4. Pararenal body: It consists of variable amount of fat lying outside the 
renal fascia. It fill up the para vertebral gutter and forms a cushion for 
the kidney. 
 The depressed part present in medial border is called the hilum. It is about 2 to 
2.5cm long. Hilum leads in to the renal sinus within the kidney. It is traversed 
by renal Artery, tributaries of renal vein and the Renal pelvis. 
 Renal pelvis is divided into 3 to 4 major calyces. These are divided into 7 to 14 
minor calyces. Each minor calyces. Each minor calyx ends into an expansion, 
Which is intended by 1 to 3 renal papillae and is perforated by collecting 
tubules open on the summit of the Renal papillae. The Renal papillae are 
Nipple like projection in the wall of the renal sinus and represents the apices of 
the Renal pyramids. 
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 Naked eye examination of the coronal section of the kidneys shows on outer 
reddish brown cortex and the inner pale medulla. The Renal medulla is made 
up of about 101-4 conical masses called renal pyramids. These apices forms the 
renal papillae which indend the minor calyces and discharge urine into them 
through the opening of the ducts of Bellini. 
 Histologically, each kidney is composed of 1-3 million uriniferous tubules. 
Each tubules are consists of two parts. 
a. The secretary part which forms urine is called the nephron. The 
Nephron. The Nephron is the functional unit of the kidney. 
b. Nephrons opens into collecting tubules. 
 The kidney cannot regenerate new Nephrons. Therefore with renal injury, 
disease or normal ageing, there is gradual decrease in nephron number. After 
age 40, the number of functioning nephrons usually decreases about 10 percent 
every 10 years. Thus at age 80 many people have 40 percent fewer functioning 
Nephorns than they did at age 40. This loss is not life threatening because 
adaptive changes in the remaining nephrons allow them to excrete the proper 
amounts of water, electrolytes and waste products. 
 Each Nephron contains, a tuft of glomerular capillaries called the glomerulus, 
through which large amount of fluid are filtered from the blood. A long tubule 
in which the filtered fluid is converted into urine on its way to the pelvis of the 
kidney. 
 The glomerulus contains a network of branching and anastamosing glomerular 
capillaries that, compared with other capillaries, have high hydrostatic pressure 
(about 60mm Hg). The glomerular capillaries are covered by epithelial cells, 
The total glomerulus’s is encased in Bowman’s capsule. Fluid filtered from the 
glomerulus’s capillaries flows into Bowman’s capsule and then into the 
proximal tubule which lies in the cortex of the kidney. 
38 
 
 From the proximal tubule, fluid flows into the loop of henle, which dips into 
the renal medulla. Each loop consists of the descending and an ascending limb. 
The walls of the descending limb and the lower end of the ascending limb are 
very thin and therefore are called the thin segment of the loop of Henle. After 
ascending limb of the loop has returned part way back to the cortex, its wall 
becomes thick like other portions of the tubular system and it is therefore 
referred to as the thick segment of the ascending limb. 
 At the end of the thick ascending limb is a short segment, which is actually a 
plaque in its wall, known as the macula densa. The macula densa plays an 
important role in controlling nephron function. Beyond the macula densa, fluid 
enters the distal tubule that, like the proximal tubule lies in the renal cortex. 
This is followed by the connecting tubule and the cortical collecting tubule 
duct. The initial parts of 8 to 10 cortical collecting ducts join to form a single 
larger collecting ducts that runs downwards into the medulla and becomes the 
modularly collecting duct. The collecting ducts merge to form progressively 
larger ducts that eventually empty into the renal pelvis through the tips of the 
renal papillae into the renal pelvis through the tips of the renal papillae. In each 
kidney, there are about 250 of the very large collecting ducts, each of which 
collects urine from about 4000 nephrons. 
Blood Supply 
 Usually there is one renal artery on each side, arising from the Abdominal 
Aorta. Accessory renal arteries are present in 30% of individuals; they arise 
commonly from the aorts, run parallel to the renal artery, and enter the kidney 
either at the hilum at one of its poles. 
 At or near the hilum the renal artery divides into anterior and posterior 
divisions. Further branching of these divisions gives rise to segmental arteries 
each of which supplies one vascular segment. Five  such segments are 
described these are Apical, Upper, Middle, lower and Posterior. The segments 
are independent units. 
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Venous Drainage 
 The capillaries surrounding the tubules from various plexus and there form 
veins which accompany the corresponding Arteries forming the interlobular, 
actuate and interlooper veins ultimately to form the renal vein near the hilum 
and emerge out from it and open into inferior Venacava. 
Nerve supply 
 The kidney supplied by the renal plexus, and offshoot of the celiac plexus. It 
contains sympathetic (T10-L1) fibers which are chiefly vasomotor. The 
afferent nerves of the kidney belong to segments T10-T12. 
Mechanism or Urine formation 
The process involved in urine formation are, 
1. Glomerular filtration 
2. Tubular secretion 
3. Tubular reabsorption 
Glomerular filteration 
 Glomerular filterate is a protein free plasma. Glomerular filteration is depend 
upon hydrostatic pressure of the afferent arterioles, the plasma proteins causing 
Osmotic pressure renal tubular pressure. The glomerular filter contains all the 
substance present in the plasma except colloids. 
 About 170 liters of glomerular filterate enters the renal tubule per day and 
about 168.5 liters of urine reabsorbed in the renal tubule. 
 Normal amount of urine excreted per day is about 1.5 litres. The glomerular 
filterate is alkaline. It contains water, small quantities of urea, glucose, 
potassium, calcium, bicarbonates and uric acid. 
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Tubular reabsorption  
 99% of glomerular filterate is reabsorbed in the renal tubule. Active 
reabsorption of sodium, potassium, glucose, amino acids, phosphate, calcium 
and uric acid occurs in the proximal convoluted tubule. 7/8 water present in the 
glomerular filterate absorbed at proximal convoluted tubule.  This is called 
obligatory fraction. 
 Passive reabsorption of 80% of water is diffused out of the tubule. Thus the 
fluid within the tubule takes with it urea to diffuse out of the tubule. Sodium 
chloride concentration becomes grater within loop of Henle. Then the sodium 
chloride is reabsorbed by blood vessels accompanying the loop of Henle (Vasa 
recta). Along with this water also enters the vasa recta group of blood vessels. 
 In the distal convoluted tubule reabsorption of 1/8 of water occurs in the 
influence of anti diuretic hormone secreted by the posterior lobe of pituitary 
gland.Bicarbonates and chlorides are also reabsorbed in the distal convoluted 
tubule. 
Tubular secretion 
 This occurs commonly within the convoluted tubule. When any substance is 
found excess in the blood, it is secreted into the urine Drug, mercurial diuretics, 
ammonium, potassium, hydrogen ion etc. are excreted by tubular secretion. 
FUNCTIONS OF KIDNEYS 
 Kidneys perform vital functions. By excreting urine, kidneys play principal 
role in the maintenance of Internal environment. In addition, kidneys perform 
many other functions as described below. 
Role in Homeostasis  
 The primary function of kidneys is homeostasis. It is accomplished by the 
formation of urine. Kidneys are not only the excretory organs, but are also the 
regulatory organs their major role is in homeostasis. During the formation of 
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urine, kidneys regulate various activities in the body, which are concerned with 
homeostasis. 
i.Excretion of waste products 
 Kidneys excrete the unwanted waste products which are formed during 
metabolic activities. 
a.  Urea  - End product of amino acid metabolism 
b.Uric Acid  - End product of nucleic acid metabolism. 
c.  Creatinine - End product of metabolism in muscles. 
d.Bilirubin  - End product of hemoglobin degradation. 
e.  Products of metabolism of other substances. 
Kidneys also excrete harmful foreign chemical substances like. 
a.  Toxins 
b.Drugs 
c.  Heavy metals 
d.Pesticides etc. 
ii.Maintenance of water balance 
 Kidneys maintain the water balance in the body by conserving water when it is 
decreased and excreting water when it is excess in the body. 
iii. Maintenance of Electrolyte Balance 
 Maintenance of electrolyte balance, especially sodium in relation to water 
balance. Kidneys retain sodium if the osmolarity of body water decreases and 
eliminate sodium when osmolarity increases. 
 
 
  
42 
 
iv. Maintenance of acid Base balance 
 The pH of the blood and body fluids should be maintained within narrow range 
for healthy living. Body is under constant threat to develop acidosis, because of 
production of lot of acids during metabolic activities. However it is prevented 
by kidneys, lungs and blood buffers which eliminate these acids. Among these 
organs, kidneys play major role in preventing acidosis. In fact, kidneys are the 
only organs, which are capable of eliminating certain metabolic acids like 
sulphuric and phosphoric acids.       
2.Hemopoietic function 
 Kidneys stimulate the production of erythrocytes by secreting erythropoietin. 
Erythropoietin is the important stimulating factor for erythropoiesis. Kidneys 
also secrete another factor called thrombopoietin, which stimulates the 
production the thrombocytes. 
3.Endocrine function 
 The hormones secreted by kidneys are, 
i. Erythropoietin 
ii. Thrombopoietin 
iii. Renin 
iv. 1,25 dihydroxy cholecalciferol 
v. Prostaglandins. 
4.Regulation of Blood pressure 
 Kidneys play an important role in the regulation of arterial blood pressure, 
Kidneys regulate arterial blood pressure by two ways. 
i. By regulating the volume of extracellular fluid 
ii. Through rennin – angiotensin mechanism. 
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THE URETERS 
 The ureters are a pair of narrow, thick walled tubes which convey urine from 
the kidney to the urinary bladder. It lies deep to the peritoneum closely applied 
to the posterior abdominal wall in the upper part and the lateral pelvic wall in 
the lower part. Each ureter is about 25cm long (10 inches) and it measures 
about 3mm diameter. Upper half lies in the abdomen, the lower half lies in the 
pelvis. 
 Ureter begins within renal sinus as a funnel shaped dilatation called renal 
pelvis. It descends along the median margin and partly behind. It gradually 
narrows till the lower end of the kidney than the ureter passes downwards and 
slightly medially on the psoas major muscle and enter the pelvis by crossing in 
front of the termination of common iliac artery. 
 In the true pelvis the ureter at first runs downwards and slightly back wards and 
laterally, following the anterior margin of the greater sciatic notch. Opposite 
the ischial spine it turns forwards and medially to reach the base of the urinary 
bladder. 
 The ureter enter the bladder wall obliquely to open into it at the lateral angle of  
its trigone. 
Normal Constrictions 
 The ureter is slightly constricted at three places. The first, at pelvic urethral 
junction about 5.5 cm below the hilum of the kidney. Second at Brim of the 
pelvis where the ureter crosses in front of the common iliac artery. Third is just 
before it enters the bladder. The renal stones tend to get arrested at these places.  
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Blood Supply 
 Upper part receives branches from Renal Artery, middle part receives from 
Aorta, the gonadal and iliac vessels. The pelvic part is supplied by the vessel, 
the middle rectal or uterine vessels. 
Nerve Supply 
 The ureter is supplied by sympathetic (T10-L1)  and para sympathetic (S2-S4). 
They reach the ureter through the renal, aortic and hypogastric plexuses. All the 
nerves appear to be sensory in function. 
URINARY BLADDER 
 It is a hollow muscular organ which served to collect urine and to discharge to 
it out periodically. It lies in the anterior part of pelvic cavity. In front of 
Rectum in males and in front of uterus in females. 
 The bladder varies in its size, shape and position, according to the amount of 
urine is contained and the age of the person, when empty it lies entirely within 
the pelvis. But as if filled it expands into the abdominal cavity reaching upto 
umbilicus and becomes the abdominus. 
 Empty constricted bladder resembles 4 sided pyramid. It has 4 angles -Apex, 
Neck, Two Lateral angle, 4 surfaces – Superior, Posterior, 2 infero lateral 
surfaces, 4 Borders – Anterior, Posterior, 2 lateral Borders. 
 Distended bladder ovoid in shape. Since its angle and borders were rounded. In 
the fetus and new born even the empty borders abdominal. At age “6” bladder 
comes down to definite position and pelvic organ. Normal capacity of urinary 
bladder is about 200-300 etc. 
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Internal sphincter of the bladder 
 The bladder wall is made up of longitudinal and circular layers of smooth 
muscles and they are called detrusor muscle. In the trigone in addition to 
detrusor muscle. There is trigonal muscle of bell. There is original muscle of 
bell. There is no definite circular muscle fibre at the neck of the bladder stop at 
the level of neck. Longitudinal fibres from the posterior wall diverge to pass 
around the urethra on both sides. 
Blood Supply   
 Superior vesicle arteries and inferior vesicle arteries supplies to the bladder. In 
addition branches from obturator and inferior gluteal Artery are supplied to the 
bladder. 
Nerve Supply 
 Symphathetic fibres arises from T11-L2 segment. Parasymphathetic fibres 
branches from S2-S4. 
URETHRA 
 Urethra is a tubular passage extending from the neck of the bladder to the 
external urethral orifice. 
 The male urethra extends from the internal urethral orifice at the neck of 
urinary bladder to the external urethral orifice at the tip of the penis. It is about 
20 cm long in flaccid state of the penis the long axis of urethra shows 2 
curvature and is therefore “S” shaped. In the erect state it become “J” shaped. 
 It is divided into 3 parts 
1. Prostatic part  : Passes through prostate (3cm long) 
2. Membraneous part : Surrounded by sphincter (2cm long) 
3. Spongy part (penile part) : Passes through the bulb and carpus 
spongiosum (15cm long)  
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Sphincter of the Urethra 
 There are 2 spincters, in relation with urethra internal and external. The internal 
sphincter made up of smooth muscle firbre and situated at the neck of the 
bladder is supplied by sympathetic nerves from lower thoracic segments and 
upper lumber segments. 
 The externals sphincter made of light striated muscle fibfe surrounds the 
membrancous part of urethra it is supplied by perineal branch of the pudental 
erve (S2 to S4) 
Blood Supply 
 Branches of internal pudental Artery 
THE FEMALE URETHRA 
 The female urethra is only 4cm long and 6mm in diameter. Developmentally it 
correspondents to the upper part of the prostatic urethra of the male. 
 It begins at the internal urethral orifices roughly 5cm behind the middle of the 
pubic symphysis. It runs downwards and forwards embedded in the anterior 
wall of the vagina, traverses the urogenital diaphragm and ends at the lateral 
urethral orifices in the vestibule. 
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RENAL CALCULI (UROLITHIASIS) 
Definition  
 A condition in which one or more stones are present in the pelvis or calyces of 
the kidney or in the ureter. 
Causes incidence and risk factors 
 A Kidney stone results when the urine becomes too concentrated and 
substances in the crystallize to form stones. Stones maynot produce symptoms 
until they begin to move down the ureter, causing pain. The pain, is severe, 
located in the flank and often described as worst pain ever experienced. 
 Kidney stones are common. About 5% of women and 10% of men will have 
atleast one episode by age 70. Kidney stones affect about 2 out of every 100 
people. Recurrence is common and the risk of recurrence is greater if two or 
more episodes of kidney stones occur. Kidney stones are common in premature 
infants. 
 Some types of stones tend to run in families. Some types may be associate with 
other conditions which as bowel disease, ileal by pass for obesity or renal 
tubule defects. A personal or family history of stones is asassociated with 
increased risk of stone formation. Other risk factors include tubular acidosis 
and resultant nephrocalcinosis. 
 Calcium stones are most common accounting for 75% to 95% of the stones. 
They are two or three times more common in men, usually appearing at age 
320-30. Recurrence is likely. The calcium may combine with other substances 
such as oxalate (the most common substance) phosphate or carbonate to form 
the stone. Oxalate is present in certain foods. Disease of small intestine 
increase the tendency to form calcium oxalate stones. 
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 Uric acid stones may form in persons with cystinuria. It is a hereditary 
disorders affecting both men and women. 
 Struvite stones are mainly found in women as a result of urinary tract infection. 
They can few very large and obstruct the kidney ureter or bladder.  
Aetiology: 
 Risk factors that enhance the stone formation are 
 Metabolic state (influenced by patient’s genetic background) Common 
metabolic conditions that predispose to the formation of urinary stones are : 
 Idiopathic hypercalciuria is present in approx 50% of the stone forming 
patients in the urinary stones. It is divided into absorptive (due to excess GI 
absorption of Calcium ) Renal type (due to renal leak of calcium) 
 Hyper Calciurea (with or without gout) is present in approx 30% of stone 
formers. Increased Uric acid excretion can also contribute to the formation of 
calcium containing stones. 
 Hyperoxaluria of various causes is present in about 15% 
 Low urinary citrate excretion is present in about 50% and can contribute to 
stone formation in most states. 
 Conditions associated with hypercalciuria and Hyperoxaluria 
1. High dietary intake of calcium (dairy product) 
2. Hyperparathyrodism 
3. Hyper Vitaminosis D 
4. Cushing’s Syndrome 
5. Renal tubular acidosis 
6. Idiopathic hypercalciuria – Excessive absorption of calcium from a 
gut reduced respiratory tract absorption of filtered calcium 
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Hyper Oxaluria 
1. High dietary intake of the fruit and vegetables. 
2. Increased absorption of oxalate from gut 
a) Heat disease 
b) Low calcium diet 
Hormonal imbalance  
Hyper parathyroidism 
 This occurs due to increased secretion of parathyroid hormone by hyper active 
and hyperplastic tumours of parathyroid. In this condition there is increased 
urinary excretion of calcium and phosphorus. So it will deposit easily in 
urinary tract from the stone. 
Environmental risk factors 
 A low urine volume is clearly with an increased risk of stones. Though not well 
documented there does appear to be an increased risk for patients in hotter 
climate or working conditions, at least during an initial acelimatization period. 
Dietary Excesses 
 In Vit-D poisoning intestinal absorption of calcium and phosphorus increased. 
So more amount of Ca and P will be excreted via kidney by urine. So it will 
easily deposit and form stone easily. 
Vit. A deficiency 
 It may cause a widespread atrophy of mucous membrance of Genito-urinary 
tract. When the mucous membrane of the urinary tract gets keratinized, the 
desquamated cells from the nidus on which salts of calcium and phosphous 
from urine precipitate and form calculus. This is more applicable to bladder 
calculus. 
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Urine pH effect urinary stone formation 
 In general an alkaline urine pH favours precipitation of inorganic stones – 
calcium, phosphate, and magnesium ammonium phosphate (Struvite). An acid 
pH>5.5 favours precipitation of organic stones uric acid and cystine. 
 Urine pH has little effect on calcium oxalate solubility and therefore little 
influence on formation of these stones. 
Chronic UTI 
a) Infection disturbs the colloid content of the urine, so there is 
more chance of the stone formation. 
b) Infection also causes abnormalities in the colloids, which may 
cause the crystalloid to be precipitated. 
c) Infection also change urinary pH, which helps in stone 
formation (eg. Proteus and staphylococcus) 
d) Increased in concentration of crystalloids, which may under 
some circumstances produce stones. 
Altered urinary Crystalloid and colloids 
 In urine there are quite a number of different types of crystalloids. These are 
kept in solution by the patients of colloids in the urine by process of absorption. 
 Urinary crystalloids are (eg) oxalate, calcium, cystine, uric acid, phosphate etc. 
 Urinary colloids are – mucin, chondroitin, sulphuric acid. 
 When there is imbalance in the crystalloid – colloid ratio, either there is an 
increase in the crystalloid level or a fall in the colloid level: urinary stones may 
formed. 
 If there is any modification in crystalloids eg. If they loose their solvent action 
or adhesive property, urinary stones may develop. 
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Urinary Stasis 
 Stones are more prone to occur when there is obstruction to the free passage of 
urine. 
1. Urinary staisis provide a fertile field for bacterial growth and also 
predispose to urinary infection. 
2. It also shifts the pH of the urine into alkaline side. 
3. It allows crystalloids to precipitate 
Mechanical Cause 
 Three mechanism currently thought to contribute to urinary stone formation are 
1.Precipitation  - Crystallization from Super Saturated Solutions. 
2.Absence of inhibits of stone formation normally presents in urine 
3.Presence of macromolecular matrix 
 Precipitation of a substance to form stones depend on many factors including 
solubility, concentration and urine characteristics i.e. pH 7 
 Normal constituents of urine that inhibit stone formation include citrate 
pyrosphosphate and magnesium. Reduced concentration of these substances are 
felt to contribute stone formation. Disease caused Renal Calculi is Gout – it 
forms the urate Calculus. 
Types of Stones 
1. Primary Stones 
2. Secondary Stones. 
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PRIMARY STONES 
 Which appear in apparently normal urinary tract without any antecedent 
inflammation. These stones are usually formed in acid urine. These stones 
usually consist of 
1. Calcium oxalate 
2. Uric acid and Urate Calculi 
3. Cystine Calculi 
4. Xanthine Calculi 
5. Indigo Calculi 
Uric acid and Urate Calculus 
 Uric and stones form in acidic urine. In Israle, the incidence is as high as 25% 
Dalmation coach dog is the only mammal, at risk for formation or uric acid 
urinary lithiasis. 
 The risk is roughly equal to that of human do not possess the hepatic enzyme 
uricase, found in other mammals which form the water insoluble uric acid into 
ailantom, which is freely soluble and excreated by the Kidney. The 
consequency of this enzyme defect is that humans and Dalmation dogs have 
uric acid levels that are 10 times greater than those of other mammal. 
Etiology 
 Uric acid is the end product of purine metabolism and the supersaturation of 
urine with the undissociated uric acid is needed for the development of uric 
acid crystals. 
Diet restriction 
Red Meat 
Beef 
Chicken 
Fish 
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Peanuts and 
Liver which are rich in purine. 
Cystine Calculi 
Cystine stones are rare only 1-2% have cystine stones. 
Causes 
 Cystine stones result from an inherited defect of renal tubular reabsorption of 
cystine. Actually the tubular defect affects the reabsorption of the following 4 
dibasic amino acids. 
1. Cystine 
2. Ornithine 
3. Lysine and 
4. Arginine 
 In above these amino acids, only cystine is insoluble and will precipitate in 
urine and to form stones. 
 In an autosomal recessive fashion, if both parents are carriers the sibling may 
have a 25% chance of  being affected. 
Management 
 3-4 quarts of oral fluids per day should be ingested to decrease the urinary 
concentration of cystine. 
 The urine should be alkalinized because cystine is more soluble in alkaline 
urine. 
Diet 
 Sulphur containing proteins such as meat, fish and Eggs should be restricted. 
 Carbohydrate and fats may be increased in the diet along with low sulphur 
content proteins. 
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Nature of Cystine Stone 
Colourless 
Dense consistency 
Pure Cystine stone not radio opaque but with sulphur it will radio opaque. 
Xanthine Calculi 
Extremely rare 
Smooth round and brick red colour 
On cut surface it shows lamellar appearance 
 Xanthine is a precursor of uric acid. It is found in most bodily fluids. 
Xanthinuria is a rare hereditary disorder of purine metabolism due to 
deficiency of the enzyme xanthine oxidase which cause excessive urinary 
secretion of Xanthine will form Xanthine Crystals. 
Indigo Stones 
 Indigo stones are uncommon that there are merely academic curiosities. This is 
blue in colour and are derived from Indicon, formed by decomposition of 
tryptophan in the intestine and found in the urine. 
 Tryptophan naturally occurring amino acid excisting in proteins and essential 
for human metabolism. 
 Now we can see the detailed facts about the calcium oxalate stones. 
Calcium Oxalate Stones\ 
 It is an inorganic stone, it forms in alkaline urine calcium oxalate calculi may 
first come to medical attention when they cause pain or Haematururia. The 
symptoms usually result from acute obstruction of calcium. Stones may be 
found at radiography evaluation. 
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Nature of Calcium Stones 
Calcium Oxalate  
 Colour strained black with blood pigments. It readily damage the mucous 
membrane. 
Calcium phosphate 
 Greyish white colour, loose, crumbly rough. Very hard consistency. 
Causes for formation of calcium Oxalate Stones 
1. They form when the urine is super saturated with calcium oxalate i.e. 
when the concentration of calcium oxalate in the urine exceeds its 
solubility. 
2. Hotter climates – A low urine volume is clearly associated with an 
increased risk of stone formation. 
Diet restriction  
1. A high fluid intake is most important as it will increase urinary 
volume and decrease the concentration of calcium oxalate. 
2. Tea, nuts and some green leafy vegetables are high in oxalates. 
3. Restriction of salt and fat intake. 
4. Dairy products 
5. Foods high in oxalates are Tomato, strawberries, plumbs, spinach 
etc. 
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FOODS AND DRINKS CONTAINING CALCIUM OXALATE 
 A diet low in oxalates are more reasonable than a calcium restricted diet. 
 Apples, Grapes, Asparagus, Ice Cream, Beer, Milk, Beets, Oranges, Berries, 
Peanut butter, Black pepper, Pine apples, Cheese, Spinach, Chocolate, Tea, 
Cocoa, Turnips, Coffee, Vitamin C, Cola drinks, Yogart, Figs. These foods can 
be eaten in very limited amounts under the advice of the doctor. 
SECONDARY STONES 
1.Phosphate calculus or struvite stones 
 A struvite stone is formed due to infection in the urinary tract and so it is a 
secondary calculus. Struvite stone is a mixture of magnesium ammonium 
phosphate and carbonate apatite. App. 5- 20% 
 Phosphate stone may occur as covering of a primary stone. Such stones are 
known as mixed stones. The primary stone is often the calcium oxalate stone. 
When the urine becomes infected deposits of phosphates occur on the rough 
surface of calcium oxalate stones. 
Clinical Features 
 Symptom can be divided into 4 groups. 
1.Quiescent Calculus 
 A few stones, particularly the phosphate stones, may ie. Dormant for quiet a 
long period. During the time the stones gradually increase in size with 
destruction of renal parenchyma. Such stones are may be discovered 
accidentally in X-ray performed for some other reason or first revealed with 
renal failure ureaemia. 
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 Sometimes such stones are discovered due to symptoms of urinary infection. 
When the stone is still in the submucosal stage (randalls plaque) or adherent to 
the parenchyma, it may be symptomless. Even stag horn calculus may be 
asymptomatic. 
2.  Pain 
 It is a leading symptom of renal calculi in majority of cases (80%). 
 3 types of pain are usually noticed viz. 
a)  Fixed Renal pain 
b) Ureteric Colic Pain 
c) Referred pain 
a) Fixed Renal pain 
i) If the stone is free and obstructs a calyx or uretero pelvic junction 
this will be dull flank pain due to capsular and parenchymal 
distension. 
ii) Dull aching or boring type of pain is also experienced in case of 
big phosphate calculus. 
iii) The pain is situated in the renal angle posteriorly and in the 
corresponding hypochondrium anteriorly. 
iv) This pain characteristically coarse on movement particularly 
walking up the stairs and during jolting. 
b) Ureteric colic  
1. It is due to the stone attempts to pass down the ureter and temporary 
blocks the pelvi ureteric junction. 
2. It is an agonizing pain and radiates from loin to groin. 
3. The pain comes on suddenly, during which the patients rolls and 
drawing up his knees towards the chest tossing on the bed in agony. 
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4. Profuse sweating, nausea and vomiting accompany this colic. The pulse 
quickens and temperature goes down below normal. The typical 
radiation of the colicky pain is due to reflex pain which takes place 
along the course, Of the iliohypogastric and ilioinguinal nerves which 
are the somatic nerves of the same segments which supply the 
autonomic nervous system to the ureter. (T11, T12 and S1) 
5. Sometimes the pain is referred to the scrotum or labium majora and to 
the inner side of the thigh along the distribution of Genito femoral nerve 
when the stone is in the lower part of the ureter. In male the testes may 
be retracted by spasm of cremaster and tenderness may persist for some 
days after the colic ceased. 
6. When the stone is in the intra mural part of the ureter strangury may 
occur. The colicky pain persists for a variable period usually 6-8 hrs and 
passes off as suddenly as it came. Ureteric colic may pass off with 
compensatory polyuria for passage of stones in the urine. 
c)  Referred pain 
 This is quite rare and is sometimes referred to all over the abdomen. 
Such pain may stimulate peptic ulcer or gall bladder disease. Some times pain 
may referred to the opposite kidney which is known as renorenal reflex. 
3) Hydronephrosis 
 Sometimes partients complaints of a lump in the loin and a dull ache 
which are due to hydronephrosis caused by renal stone. 
4) Haematuria 
 Is the leading symptom. It usually occurs in small amount to make the 
urine dirty or smoky during or after an attack of pain. 
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 Infection of the kidney may occur due to stone, which is relatively 
symptomless. Patients presents with pus in the urine. 
Physical Signs 
 In majority of cases characteristic physical signs are not present. The 
signs which may be present and should be looked for are  
1. Tenderness  
 This is mostly present at the renal angle posteriorly. Tenderness is more 
a constant feature when renal calculus is associated with infection. 
2. Muscle rigidity over the kidney may be found in a few cases. Rebound 
tenderness anteriorly can also be elicited, particularly if acute infection 
is associated with 
3. Swelling – when there is hydronephrosis or pyelonephrosis associated 
with renal calculus a swelling may be felt in the flank. 
URETERIC CALCULUS 
 A stone in the ureter always originates from the kidney. Ureteric colic is 
the main symptom of this condition. Haematuria may be complained of. 
Ureteric colic starts as soon as the stone enters the pelvic ureteric juctions and 
recurs at longer or shorter intervals so long as the stone remains in the ureter. 
Ureteric colic ceases when the stone is ejected into the bladder or the stone is 
impacted in the ureter. When the stone is in the upper 1/3 rd of ureter, pain 
starts in the loin or near the renal angle and gradually radiates to the groin. Pain 
is griping in nature and starts suddenly. The patients almost tosses over the bed 
in agony often associated with profuse sweating and nausea. Pain suddenly 
goes off almost as suddenly as it appearted. At a lower level, pain commences 
rather anteriorly just above the iliac crest and is referred along the two branches 
of the genitor femoral nerve to the testis in the male, and Labium majus in the 
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female and to the antero – medical aspect of the thigh in both sexes. The testis 
becomes retracted by the spasm of the cremaster. When the stone enters the 
intramural part of the ureter, pain is referred to the tip of the penis and the 
patient complains of strangury. When the stone becomes impacted, colic goes 
off, instead a dull ache araise according to the site of impaction. Such pain 
varies in intensity, increased by exercise and relieved by rest. In the right side 
this conditions may be confused with appendicitis. 
 On examination, tenderness and rigidity may be felt along the course of 
the ureter. A stone in the lower part of the ureter may be felt in rectal or vaginal 
examination. 
 Straight X-ray often reveals often stone alsong the course of ureter. 
Urography will reveal a non-opaque stone by filling defect. No excretion or 
delayed excretion in sometimes seen after an attack of ureteric colic. 
Cystoscopy will reveal a stone at the ureteric orifice. It will show delayed or no 
excretion after intra venous injection of indigocarmine. 
VESICAL CALCULUS 
 Stone may come to the bladder through the ureter and enlarges here. 
Otherwise stone may form in the bladder secondary to stasis and infection. 
 No age is exempt from this disease. Males are much more often affected 
than females. Increased frequenc of micturation is the commonest symptom. 
This is not experienced at night. The cause is that in standing posture the stone 
comes in contest with the trigone an initiates desire to micturate. During night 
the stone falls off the trigone and frequent desire to micturate goes off. 
Presence of stone in the bladder will give rise to pain in the supra pelvic region 
particularly after micturation. This pain is often referred to the tip of the penis 
or to the Labia majora and becomes aggravated by running and jolting. 
Children may scream and pull the prepuce for after micturation. Haematuria at 
the end of the micturation to also common symptom. This is caused by 
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abrasion of vascular trigone and gets worse on exercise. Sudden interruption of 
the flow due to blockage of the urethral meatus with the stone and subsequent 
continuation by change of posture is also not uncommon. Symptoms of cystitis 
eg. Frequency of micturation, burning sensation, post public pain etc may 
overshadow. Those due to presence of stone. 
 Sometimes stone may be situated in the post – prostatic pouch or 
diverticulum without any typical symptom of stone an to only revealed in X ray 
or cystoscopy for other complaints. These are known “Latent Stone”. 
 On examination, one may elicit suprapubic tenderness. A large stone can 
be felt per rectum (in male) or per vagina (in female). But bimanual palpation 
(one on the abdomen and other in the rectum may facilitate palpitation. 
 Urine should be examined microscopically and Bacterologically, 
Straight X ray will reveal about 95% of the vesical calculus further stone on the 
ureter or kidney. Urography will show non-opaque stone by filling detect and 
demonstrates the functioning conditions of the kidney. Cystocopy and bladder 
sound will detect presence of stone as well. 
INVESTIGATIONS 
1) Blood examination 
 Calcium, Phosphate, Uric acid, Urea and electrolytes, parathyroid 
hormone – only if calcium excretion is high. 
2) Urine Analysis  
  Protein, Blood, Glucose, amino acids 
a) Physical examination 
b) Chemical examination 
c) Microscopic examination 
d) Bacteriological examination 
3. Renal function tests – Blood Urea, Creatinine 
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4. Radiography : 
 KUB – cystine stones are not radio opaque. So it may not be detectable 
in X-ray. 
 Excretion urography 
 Intravenous pyelogram 
5. Ultrasonography 
6. Computed tomography 
7. Renal scan 
8. Ureteroscopy, cystoscopy – instrumental examination 
9. 24 hour Urine 
 Urea, Cratinine Clearance, Sodium Calcium Oxalate. Uric acid. 
10. Examination of  stone. 
11. MRU (Magnetic Resonance Urography) 
12. Stone Analysis 
Prevention and recurrence  
A)  False recurrence – which means a tiny stone may overlooked any 
where in urinary tract after treatment. 
B)  True recurrence 
Preventive measures divided into 2 categories 
1. General measures 
2. Specific measures 
General measures 
 Stone must be analysed chemically to know its composition. If not 
available, we should be carefully note the following. 
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1. X-ray density 
2. Types of crystal found in urine 
3. Chemical test for cystine crystal and  
4. Abnormalities in blood chemistry (Excess of calcium phosphorus 
or uric acid) 
 In general measures or advises which should be given to the patient 
regardless of the type of stone are : 
a. Fluid intake should be high at all times. 
b. Urine should be kept acid all the time. 
c. Vitamin –D should be stopped or used in very low quantity 
Specific measures (Diet restriction) 
1) Calcium stone – Dairy products, fruits and vegetables rich in 
calcium. 
2) Oxalate tones – Tomatoes, plums, spinach etc. 
3) Uric acid and urate calculi - Red Meat, Fish, Liver 
4. Cystine Calculus 
 Sulphur containing proteins such as meat, fish, egg should be restricted. 
Carbohydrate and fat may be increased with low sulphur content proteins. 
 For prophylactic purpose it is necessary to climate all hindrances to a 
free drainage of urine (constriction, adenoma of the prostrate etc) and to 
remove foci of infection from the teeth and tonsils. 
DIFFERENTIAL DIAGNOSIS OF RENAL CALCULUS 
1. Cystitis and urinary tract infection 
2. Pyelonephritis 
3. Perinephric abscess 
64 
 
Complications of Renal Calculus 
1. Azotemiz : Increased urea and nitrogen containing compounds. 
2. Acquired distal renal tubular acidosis 
3. Urinary tract infection due to urinary stasis. 
4. Hyperkalaemia 
5. Renal hypertension 
6. Chronic Unilateral or bilateral hydronephrosis in the presence of ECV 
expansion or other renal disease. 
7. Polycythaemia – infrequent complication of obstructive uropathy 
secondary to increased erythropoietin production by the obstructed 
kidney. 
Treatment of stone disease 
 The medical management of urolithiasis involves mainly two aspects : 
one that is aimed at dissolution of preexisting stones and there, at preventing 
the recurrence of stones. Surgical treatment is method of choice for removing 
previously existing stones while appropriate therapeutic treatment has to be 
chosen for prevention or recurring stones. 
Surgical Treatment 
 Depending upon the location of the stone, either operative or 
endoscopic approach is chosen. Endoscopic method is preferred for stones 
located distal to the bladder. Some of the non – operative techniques devised 
are extra – corporeal shock wave lithotripsy (ESWL), precutaneous 
nephrolithotomy (PCNL) and Cystolithotripsy. These also cause side effects 
such as hemorrhage, hypertension, tubular necrosis and subsequent fibrosis of 
the kidney. 
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TRIAL MEDICINE 
Nkfuhrhq;f#uzk; 
Mjhuk;:Mj;kul;rhkpu;jk; g.vz;:430 
NrUk; ruf;Ffs;: 
ntl;bNtu;, rPufk;, rhjpf;fha;, rhjpg;gj;jpup, re;jdk;, fu;flfrpq;fp, 
jf;Nfhyk;, ney;yptw;wy;, rpWehfg;g+, Nfh\;lk;, Fq;Fkg;g+, 
epyg;gidf;fpoq;F, uõ©øµ©Pµ¢u®, mKf;fuhf;fpoq;F, Ngupr;rk;gok;, 
jpuhl;irg;gok;, Rf;F, kpsF, jpg;gpyp, thy;kpsF, mfpy;fl;il, 
,ytq;fg;gl;il, new;nghup, £aøŒUPØ§µ®, NfhNuhrid-,it 
tiff;F½gyk; (17.5 fpuhk;). 
nra;Kiw: 
Nkw;fz;l ruf;Ffis ,bj;Jf;fye;J t];jpufhak; nra;J  
vLj;Jf;nfhz;L mjw;Fr; rkmsT rPdp fye;JvLj;Jf; nfhs;sTk;. 
msT:2Ntis1 fpuhk; 
mDkhdk; :gRntz;nza; 
ehs; msT: 1 kz;lyk; (48 ehl;fs;) 
 jPUk; Neha;fs;;: iffhy; vupT, fy;yilg;G, ePu;j;jhiu top Nkhu;Nghy; 
,wq;Fk; fw;gpukpak; ,ePu;r;RUr;F,cly;twl;rpMfpaNeha;fs; ePq;Fk;. 
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TRIAL DRUGS 
     ELAVANGAPATTAI                     VETTIVER                                    SEERAGAM 
 
 
 
 
 
                  SATHIKKAI                                                                     LAVANGAM                                                    
 
 
 
 
         
     VAALMILAGU                          PACCHAIKARPURAM                   ADHIMATHURAM 
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      KOROSANAI                             JATHIPATTHIRI                    KUNGUMAPPOO             
 
   SANTHANAM                           AKHILKATTAI                              SIRUNAGAPOO        
 
THAMARAI                                    THIRATCHAI                                          AMUKKARA         
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             BAERITCHAI                                           NILAPPANAI                                         KADUKKAI   
 
 
 
 
 
 
 
 
 
                 
                             NEL                                                                                   NELLI VATTRAL                                                       
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ACTIONS OF TRIAL DRUGS(According ToGunapadamMooligai) 
Drugs Botanical Name Actions 
ntl;bNth; Veteveria zizanoides rpWePu;ngUf;fp, rptfw;wp 
rPufk; Cuminum cyminum Fspu;r;rpAz;lhf;fp 
rhjpf;fha; Myristica officinalis cwf;fKz;lhf;fpmfl;Ltha;tfw;wp 
rhjpg;gj;jphp Myristica officinalis cwf;fKz;lhf;fpmfl;Ltha;tfw;wp 
re;jdk; Santalum album rpWePu;ngUf;fpFspu;r;rpAz;lhf;fp 
rpWehfg;g+ Mesua ferrea Ãf;fkfw;wp,Jtu;g;gp 
Nfh\;lk; Costus speciosus rpWePu;ngUf;fp,cukhf;fp 
Fq;Fkg;g+ Crocus sativus ,rptfw;wp,Jaulf;fp 
fpuhk;G Syzygium aromaticum ,rptfw;wp,mfl;Ltha;tfw;wp 
jhkiukfue;jk; Nelumbo nucifera cs;soyhw;wp,jhJntg;gfw;wp 
fu;flfrpq;fp      Rhussuceedenae Ãf;fkfw;wp,cukhf;fp 
jf;Nfhyk; Takkolam ntg;gfw;wp, Jtu;g;gp 
ney;yptw;wy; Phyllanthus emblica rpWePu;ngUf;fp, Fspu;r;rpAz;lhf;fp 
epyg;gidf;fpoq;F Curculigo orchoides rpWePu;ngUf;fp, Jtu;g;gp 
mKf;fuhf;fpoq;F Withania somnifera rpWePu;ngUf;fp, Ãf;fkfw;wp 
Ngupr;rk;gok; Phonex dactilifera cs;soyhw;wp, Fspu;r;rpAz;lhf;fp 
jpuhl;irgok; Vitis vinefera Fspu;r;rpAz;lhf;fp, rpWePu;ngUf;fp 
Rf;F Zingifer officinalis Ãf;fkfw;wp,ntg;gfw;wp 
kpsF Piper nigrum Ãf;fkfw;wp,er;rup 
jpg;gpyp Piper longum mfl;Ltha;tfw;wpntg;gKz;lhf;fp 
thy;kpsF Piper cubeba rpWePu;ngUf;fp,mfl;Ltha;tfw;wp 
mjpkJuk; Glycyrhiziaglabra cs;soyhw;wp,twl;rpafw;wp 
mfpy;fl;il Aqullariaagallocha Ãf;fkfw;wp,cs;soyhw;wp 
,ytq;fg;gl;il Cinnamomumzeylanica cs;soyhw;wp, ,rptfw;wp 
new;nghup Oryza sativa cs;soyhw;wp,Fspu;r;rpAz;lhf;fp 
gr;irf;fw;g+uk; Borneo camphor Fspu;r;rpAz;lhf;fp,cukhf;fp 
NfhNuhrid Felbovinumpurifactum Fspu;r;rpAz;lhf;fp, ,rptfw;wp 
 
71 
 
CHEMICAL CONSTITUENTS OF THE MAIN DRUGS 
(According to INDIAN MATERIA MEDICA) 
VETTIVER – ȕ- vetivone, Į- vetivone. 
(Diuretic , Antispasmodic) 
NILAPANAI- Merketone,glycride 
(Diuretic, emolient) 
SANTHANAM- Santalol, ȕ-sitostenol, 
(Antimicrobial, Antiseptic, Antispasmodic) 
 NELLI- Tanin(Antidiabetic, Antioxidant) 
VALMILAGU- (sesquiterpene, Hydro carbon diuretic) 
KOSTAM- Diosgenine,ȕ-Sitosterol,Saponins 
(Diuretic, coolant ,Antihelmintic) 
AMUKARA-Withanone, Withaferin. 
(Antibiotic,Anti inflammatory) 
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MATERIALS AND METHODS 
PROTOCOL 
Study Designs 
 The open clinical trial on kalladaipu was carried out in the post graduate 
department of maruthuvam in govt.  siddha medical college attached to 
arignaranna hospital of Indian medicine, Chennai-106. During the period of 
2010-2012. 
Sample Size 
 The study is conducted in 40 selected kalladaipu patients of both sexes between 
age groups of 20-60. 
Selection Criteria 
 The patients having following parameters are selected for the study. 
¾ Flank pain 
¾ Burning micturation 
¾ Nausea 
¾ Vomiting 
¾ Oliguria 
¾ Dysuria 
¾ Retention 
¾ Haematuria 
¾ Fever      
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Exclusion criteria 
x Age group less than 15 
x Staghorn calculus 
x Calculi associated with elevated serum creatinine level 
x Patient who does not complete the trial period 
x Calculi in pregnancy 
Proforma 
 The case sheet proforma for kalladaippu was prepared based on siddha 
methodology and modern aspect. 
History taking  
 For better treatments & results a detailed clinical parameter was taken 
regarding history of present illness, past illness, family history, menstrual 
history, occupational history, socio economic status residential area, etc., 
Investigation 
 All patients were screened by the following investigations. 
 This was carried out regularly before and after treatment. 
Urine examination 
Albumin  
Sugar 
Deposits 
Blood for Biochemical Examination 
 The blood was tested for sugar, urea, serum creatinine to know the renal 
function and its excretion. 
Ultra sonogram 
 Ultra sonogram of complete abdomen including KUB was done in cases to 
know the location, size and number of calculi. 
Drug and dose schedule 
 Megarajangachooranam- 1gm BD with butter for 48 days. 
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RESULTS AND OBSERVATION 
 40 cases having kalladaipu at various places were selected and treated both OP 
and IP in PG maruthuvam department. Attached to A.A.G.H.I.M. Hospital, 
Chennai- 106 during the year 2010-2012.  The result and observation during 
that clinical study are as follows. 
1) Sex distribution  
2) Age distribution 
3) Occupation 
4) According to season 
5) Distribution of thinai 
6) Distribution of mukkutram- vatham 
7) Distribution of mukkutram- pitham 
8) Distribution of mukkutram- kabam 
9) Ezhuudalthathukal 
10) Ennvagaithervugal- naadi 
11) Ennvagaithervugal 
12) Neikuri 
13) Clinical manifestation 
14) Distribution of calculi based on side 
15) Distribution of calculi based on location 
16) Results after treatment  
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1. SEX DISTRIBUTION 
SEX NUMBER OF CASES PERCENTAGE % 
Male 30 75% 
Female 10 25% 
 
SEX DISTRIBUTION 
 
  
INFERENCE 
 About 75% males and females  were 25% . 
 Literature :According to Literature males more prone to renal calculi. 
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2. AGE DISTRIBUTION  
AGE IN YEARS NUMBER OF 
CASES 
PERCENTAGE(%) 
21-30 yrs 10 25% 
31-40 yrs 15 37.5% 
41-50 yrs 12 30% 
51-60 yrs 3 7.5% 
 
AGE DISTRIBUTION 
 
 
INFERENCE 
 Majority of the cases that is 37.5% were in the 3rd decade, 25% were in the 2nd 
decade, 7.5% were in the 5th decade and 30% were in the 4th decade. 
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3. OCCUPATION 
OCCUPATION NUMBER OF 
CASES 
PERCENTAGE(%) 
House Wife 9 22.5% 
Business Man 4 10% 
Student  3 7.5% 
Teacher 3 7.5% 
Auto Driver 1 2.5% 
Mechanic 10 25% 
Office Worker 10 25% 
 
OCCUPATION 
 
INFERENCE 
 25% Were Office Worker. 22.5% were Housewife.10% were Business 
Man.7.5% Were Students & Teachers.2.5% were Auto driver, 25% were 
mechanics. 
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4. ACCORDING TO SEASON 
KALAM(season) NUMBER OF CASES PERCENTAGE(%) 
Kaar Kaalam(Aug-Oct) 8 20% 
Koothir Kaalam(Oct-Dec) 2 5% 
Munpani Kaalam(Dec-Feb) 9 22.5% 
Pinpani Kaalam(Feb-Apr) 6 15% 
Elavenir Kaalam(Apr-Jun) 11 27.5% 
Muthuvenir Kaalam(Jun-Aug) 4 10% 
 
ACCORDING TO SEASON 
 
INFERENCE 
 According to paruvakalam highest incident of 27.5% were noted in elavenir 
kaalam and 22.5% cases were noted in munpani kaalam, 20%  cases were 
noted in kaar kaalam. 
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5. DISTRIBUTION OF THINAI 
THINAI NUMBER OF CASES PERCENTAGE (%) 
Kurinchi 8 20% 
Mullai 0 0% 
Marutham 0 0% 
Neithal 32 80% 
Paalai 0 0% 
 
DISTRIBUTION OF THINAI 
 
 
INFERENCE 
 According to thinai the highest distribution 80% was noted in neithal and 20% 
was noted in kurinchi. 
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6.   DISTRIBUTION OF MUKKUTRAM- VATHAM 
VATHAM NUMBER OF CASES PERCENTAGE (%) 
Pranan - 0% 
Abanan 40 100% 
Viyanan 40 100% 
Uthanan 13 32.5% 
Samanan 8 20% 
Nagan - 0% 
Koorman 2 5% 
Kirukaran 3 7.5% 
Devathathan - 0% 
Thananjeyan - 0% 
 
DISTRIBUTION OF MUKKUTRAM- VATHAM 
 
INFERENCE 
 According To Classification Of  Vatham Derangement Of Abanan And 
Viyanan Were 100% And Uthanan Were 32.5%, Samanan Were 20%, 
Kirukaran Were 7.5%. 
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7. DISTRIBUTION OF MUKKUTRAM-PITHAM 
PITHAM NUMBER OF CASES PERCENTAGE (%) 
Analam 8 20% 
Ranjagam 9 23.5% 
Sathagam 40 100% 
Alosagam 2 5% 
Prasagam 1 2.5% 
 
 
INFERENCE 
 According to pitham 100% of cases affected by the derangement of sathagam 
and 22.5% of cases were affected by ranjagam and 20% cases were affected by 
analagam (pallor &haematuria).  
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8. DISTRIBUTION OF MUKKUTRAM-KABAM 
KABAM NUMBER OF CASES  PERCENTAGE (%) 
Avalambagam - 0% 
Klethagam 8 20% 
Pothagam 3 7.5% 
Tharpagam 2 5% 
Santhigam  2 5% 
 
DISTRIBUTION OF MUKKUTRAM-KABAM 
 
INFERENCE 
 According to kabam 20% klethagam was deranged  7.5% were affected by 
Pothagam and tharpagam and santhigam were 5%. 
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9. EZHU UDAL THATHUKAL 
EZHU UDAL 
THATHUKAL 
NUMBER 
OF CASES PERCENTAGE (%) 
Saaram 40 100% 
Senneer 9 22.5% 
Oon - 0% 
Kozhupu - 0% 
Enbu 2 5% 
Moolai - 0% 
Sukkilam/Suronitham - 0% 
   
EZHU UDAL THATHUKAL 
 
INFERENCE 
 Saaram Was Affected In 100% Of Cases. Senneer Was Affected In 22.5% Of 
Cases And Enbu In 5% Of Cases. 
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10. ENN VAGAI THERUVUGAL-NAADI 
ENNVAGAI 
THERUVUGAL 
NUMBER OF 
CASES 
PERCENTAGE(%) 
Vali azhal 15 37.5% 
Azhal vali 20 50% 
Iyya azhal 5 12.5% 
 
ENN VAGAI THERUVUGAL-NAADI 
 
 
INFERENCE 
 Azhal vali was affected in 50% of cases .vali azhal was affected in 37.5% of 
cases and iyya azhal in 12.5% of cases.  
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11. ENN VAGAI THERUVUGAL 
ENNVAGAI 
THERUVUGAL 
NUMBER OF 
CASES PERCENTAGE(%) 
Naa - - 
Niram - - 
Mozhi - - 
Vizhi 20 50% 
Sparism 10 25% 
Malam 15 37.5% 
Moothiram 40 100% 
 
ENN VAGAI THERUVUGAL 
 
INFERENCE 
  Vizhi, Sparisam, Malam, Moothiram are affected. 
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12. NEIKURI 
THATHU NEIKURI 
NUMBER OF 
CASES 
PERCENTAGE(%) 
Vatham Spread like snake 11 27.5% 
Pitham Spread like ring 23 57.5% 
Kabam Spread like pearl 6 15% 
 
NEIKURI 
 
 
INFERENCE 
 57.5% cases were having pitha neikuri.  27.5% of cases were having vatha 
neikuri and 6% cases were having kaba neikuri. 
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13. DISTRIBUTION OF CALCULI BASED ON SIDE 
SIDE 
NUMBER OF CASES PERCENTAGE (%) 
BT AT BT AT 
Rt-kidney 9 3 22.5% 33.3% 
Lt-kidney 6 4 7.5% 66.6% 
Bilateral 25 5 62.5% 20% 
 
DISTRIBUTION OF CALCULI BASED ON SIDE 
 
INFERENCE 
Before treatment:  
 Out of 40 patients 62.5% (25) were having bilateral renal calculi. 22.5% 
(9)were having Right renal calculi and 7.5% (6) were having left renal calculi. 
After treatment: 
 Out of 40 patients, after treatment 33.3% are having stones on RT kidney, 
66.6% are having LT kidney stones, 20% are having bilateral stones. 
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14. DISTRIBUTION OF CALCULI BASED ON LOCATION 
SIDE 
NUMBER OF CASES PERCENTAGE (%) 
BT AT BT AT 
Renal 36 6 90% 16.66% 
Ureteral 2 0 5% 0% 
Vesical 2 0 5% 0% 
 
DISTRIBUTION OF CALCULI BASED ON LOCATION 
 
INFERENCE 
Before Treatment 
 90% of cases were having Renal Stone, 5%  were having Ureteral stones  And 
5%  were having vesical stones. 
After Treatment 
 16.6% are having Renal stones, 0% are having ureteral stones, 0% having 
vesical stones.  
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15. CLINICAL MANIFESTATIONS 
S.NO SYMPTOMS 
NUMBER OF 
CASES PERCENTAGE 
BT AT BT AT 
1 Loin Pain 38 6 95 15 
2 Nausea 12 0 30 0 
3 Vomitting 5 0 12.5 0 
4 Burning Micturation 31 5 77.5 12.5 
5 Dysuria 16 2 40 5 
6 Oliguria 1 0 2.5 0 
7 Haematuria 3 0 7.5 0 
8 Retention 3 0 7.5 0 
9 Fever 1 0 2.5 0 
10 Other Symptoms 8 2 20 5 
 
CLINICAL MANIFESTATIONS 
 
INFERENCE 
Before Treatment 
 95% had loin pain.77.5% had burning micturation.40% had dysuria.30% had 
nausea. 
After Treatment: 
15% had loin pain.12.5% had burning micturation.5% had dysuria.5% 
had nausea. 
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16. RESULTS AFTER TREATMENT 
RESULT NUMBER OF CASES PERCENTAGE(%) 
Good 20 50% 
Fair 17 42.5% 
poor 3 7.5% 
 
RESULTS AFTER TREATMENT 
 
 
INFERENCE 
 50% showed good results both by symptoms and sonographic findings. 42.5% 
showed fair results, relieved by their symptoms and 7.5% were not relieved 
from their problem.  
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LIST OF PATIENTS 
S. 
NO 
OP. 
No 
NAME AGE/ 
SEX 
OCCUPATION DURATION 
OF ILLNESS 
DATE 
1 7610 Senthilkumar 26/M Mechanic 9-Months 13.12.2011 
2 1136 Surendhar 46/M Auto driver 5-Months 25.1.2012 
3 3265 Kavitha 35/F Housewife 8-Months 2.2.2012 
4 4321 Ushanandhini 33/F Housewife 6-Months 6.2.2012 
5 646 Padmavathy 38/F Housewife 4-Months 24.1.2012 
6 7028 Perumal 21/M Mechanic 3-Months 15.2.2012 
7 4489 Sornambigai 41/F Housewife 6-Months 13.2.2012 
8 1590 Shyamala 40/F Housewife 4-Months 2.3.2012 
9 8228 Rajendran 38/M Mechanic 6-Months 11.1.2012 
10 8227 Natarajan 43/M Mechanic 6-Months 11.1.2012 
11 9845 Velappan 29/M Student 5-Months 19-12-2011 
12 7310 Ramesh 32/M Merchant 3-Months 4.9.2012 
13 1650 Sureshbabu 32/M Mechanic 5-Months 9.4.2012 
14 3288 Pandurangan 31/M Teacher 4-Months 8.3.2012 
15 1656 Anusha 24/F IT-Eng 6-Months 2.3.2012 
16 9539 Balaji 20/M Student 2-Months 22.6.2012 
17 4553 Deenadhayalan 48/M BSNL-Optr 6-Months 5.6.2012 
18 4517 Megala 43/F Housewife 2-Months 12.7.2012 
19 306 Beermaideen 48/M Mechanic 7-Months 26.6.2012 
20 5717 Karpagam 29/F Housewife 4-Months 11.6.2012 
21 9753 Johnmartin 60/M Office work 3-Months 2.8.2012 
22 5930 Sridhar 31/M Business 4-Months 19.3.2012 
23 9776 Jaganathan 55/M Office Work 6-Months 1.8.2012 
24 285 Azharudeen 25/M Mechanic 7-Months 26.6.2012 
25 7368 Santhosh 37/M Htl Manager 6-Months 23.7.2012 
26 958 Radhakrishnan 48/M Type writer 3-Months 28.6.2012 
27 6115 Pushparaj 60/M Comp. Engr 4-Months 12.6.2012 
28 4328 Yegiyakhan 38/M Mechanic 5-Months 4.6.2012 
29 6605 Ponpandiyan 22/M Student 3-Months 19.6.2012 
30 5763 Balasubramani 40/M Teacher 6-Months 17.7.2012 
31 6323 Madhan 20/M Student 4-Months 13.6.2012 
32 4155 Elumalai 30/M Mechanic 7-Months 12.3.2012 
33 4826 Dhachayini 45/F Housewife 5-Months 13.7.2012 
34 6603 Venkatesan 47/M Electrician 6-Months 14.6.2012 
35 430 Annadurai 37/M Mechanic 3-Months 28.2.2012 
36 2358 Kennadi raja 44/M Teacher 7-Months 13.8.2012 
37 4216 Parasivam 42/M Business 3-Months 3.10.2012 
38 6608 Ganesh 33/M Merchant 4-Months 12.10.2012 
39 7788 Senthil 32/M Mechanic 6-Months 17.10.2012 
40 4572 Ramani 48/F House wife 4-Months 4.10.2012 
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RESULTS OF 40 KALLADAIPPU PATIENTS BEFORE & AFTER TREATMENT,  GOVT. SIDDHA MEDICAL COLLEGE, 
ARIGNAR ANNA HOSPITAL, CHENNAI-106 
S. 
No. 
Name of the patient 
Age/sex 
OP 
No. 
Date of 
Treatment 
Started 
Duration of 
Medicine in 
take 
Size of stone BT 
Whether stone 
expelled or not 
AT 
Remarks 
1 Senthilkumar 26/M 7610 13-12-2011 8-weeks Bilateral RT 1cm 
LT 0.7cm 
USG Normal Completed 
2 Surendhar 46/M 1136 25-01-2012 7-Weeks Bilateral RT 8mm 
LT 6mm 
One Stone expelled, 
LT3mm  
Symptoms reduced 
3 Kavitha 35/F 3265 02-02-2012 7-Weeks Bilateral 6mm USG Normal Symptoms Relieved 
4 Ushanandhini 33/F 4321 06-02-2012 7-Weeks Bilateral 5mm USG Normal Completed 
5 Padmavathy 38/F 646 24-01-2012 7-Weeks Bilateral 4mm USG Normal Completed 
6 Perumal 21/M 7028 15-02-2012 7-Weeks RT 4mm RT 4mm Advise surgery 
7 Sornambigai 41/F 4489 13-02-2012 7-Weeks RT 2 Stones (4mm) USG Normal Symptoms Relieved 
8 Shyamala 40/F 1590 2-03-2012 7-Weeks Bilateral 5mm RT 3mm 
 
Symptoms Relieved 
9 Rajendran 38/M 8228 11-01-2012 7-Weeks LT 3.4mm USG Normal  Completed 
10 Natarajan 43/M 8227 11-01-2012 7-Weeks RT 2 (4.3mm) USG Normal Completed 
11 Velappan 29/M 9845 19-12-2011 7-Weeks Bilateral gravel USG Normal Completed 
12 Ramesh 33/M 7310 4-9-2012 7-Weeks Bilateral RT 4mm 
LT 10mm,8.4mm 
One stone expelled,  
Bilateral 3mm 
Advised to continue 
Medicine. 
13 Sureshbabu 32/M 1650 9-04-2012 7-Weeks RT 4mm RT 4mm Symptoms reduced 
14 Pandurangan 31/M 3288 8-03-2012 7-Weeks LT 4.8mm LT3mm Completed 
15 Anusha 24/F 1656 2-03-2012 7-Weeks LT 6mm USG Normal Completed 
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S. 
No. 
Name of the patient 
Age/sex 
OP 
No. 
Date of 
Treatment 
Started 
Duration of 
Medicine in 
take 
Size of stone BT 
Whether stone 
expelled or not 
AT 
Remarks 
16 Balaji 20/M 9539 22-06-2012 7-Weeks Bilateral RT 5mm 
LT 6mm 
Bilateral 3mm Symptoms Relieved 
17 Venkatesan 47/M 6603 14-06-2012 7-Weeks Bilateral 4mm USG Normal Completed 
18 Deenadhayalan 48/M 4553 5-06-2012 7-Weeks Bilateral 4mm USG Normal Completed 
19 Megala 43/F 4517 12-07-2012 6-Weeks LT 10mm LT 3mm Symptoms relieved 
20 Beermaideen 48/M 306 26-06-2012 6-Weeks RT 8mm RT2mm Completed 
21 Karpagam 29/F 5717 11-06-2012 7-Weeks Bilateral 4mm USG Normal Completed 
22 Johnmartin 60/M 9753 2-08-2012 7-Weeks Bilateral RT5mm 
LT 6mm 
Bilateral 2mm Symptoms relieved 
23 Sridhar 31/M 5930 19-03-2012 7-Weeks RT 8mm USG Normal Completed 
24 Jaganathan 55/M 9776 01-08-2012 7-Weeks LT 1.8cm LT 1cm Symptoms reduced 
25 Azharudeen 25/M 285 26-06-2012 7-Weeks Bilateral  LT 6mm 
RT 6mm 
Stone expelled Completed 
26 Santhosh 37/M 7368 23-07-2012 7-Weeks RT 6mm USG Normal Completed 
27 Radhakrishnan 48/M 958 28-06-2012 7-Weeks Bilateral 
 RT 7mm LT 7mm 
RT 3mm Symptoms relieved 
28 Pushparaj 60/M 6115 12-06-2012 5-Weeks Bilateral 6mm  USG Normal Completed 
29 Yegiyakhan 38/M 4328 04-06-2012 5-Weeks Bilateral RT 5mm 
LT6mm 
USG Normal Completed 
30 Ponpandiyan 22/M 6605 19-06-2012 7-Weeks Bilateral RT4.6mm 
LT 5.9mm 
Bilateral 3mm Symptoms reduced 
31 Balasubramani 40/M 5763 17-07-2012 7-Weeks Bilateral RT10mm 
LT 5mm 
Bilateral 3mm Symptoms reduced 
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S. 
No. 
Name of the patient 
Age/sex 
OP 
No. 
Date of 
Treatment 
Started 
Duration of 
Medicine in 
take 
Size of stone BT 
Whether stone 
expelled or not 
AT 
Remarks 
32 Ramani 48/F 4572 4-10-2012 7-Weeks RT 5mm,LT 4mm USG  Normal Completed 
33 Madhan 20/M 6323 13-06-2012 5-Weeks LT 2(3.5mm) USG Normal Completed 
34 Annadurai 37/M 430 28-2-2012 6-Weeks Bilateral gravel USG Normal Completed 
35 Elumalai 30/M  4155 12-03-2012 7-Weeks RT 5.5mm USG Normal Completed 
36 Kennadi Raja 44/M 2358 13-08-2012 7-Weeks Bilateral RT 5mm 
LT 6mm 
USG Normal  
Completed 
37 Parasivam 42/M 4216 3-10-2012 7-Weeks 1cm stone in the 
bladder 
Stone expelled Completed 
38 Ganesh 33/M  6608 12-10-2012 6-Weeks RT 5mm,4mm   USG Normal  
Completed 
39 Dhachayini 45/F 4826 13-07-2012 5-Weeks Bilateral RT 3mm 
LT 3mm  
USG Normal  
Completed 
40 Senthil 32/M 7788 17-10-2012 6-Weeks Bilateral 5mm USG Normal Completed 
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LABORATORY INVESTIGATION REPORT 
SL.  
No. 
 
 
 
 
O.P.  
No. 
 
 
 
 
Name 
 
 
 
 
Age/Sex 
 
 
 
 
HAEMATOLOGICAL REPORT  URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT ESR (mm) Hb (Gm) Urea Creatinine BT AT 
TC  
CU/ 
mm 
 
 
DC% TC 
CU/ 
m m 
 
 
 BT AT BT AT BT AT BT AT Alb Sug Dep Alb Sug Dep 
P L E P L E 1/2 
hr 
1 
hr 
½ 
hr 
1 
hr 
 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
1. 7610 Senthilkumar 26/M 9000 55 38 7 10500 62 34 4 22 45 15 30 9.0 12.5 23 15 .6 .5 + NIL Opc NIL NIL NIL 
2. 1136 Surendhar 46/M 9400 59 36 5 10100 62 34 4 5 12 4 7 11.8 13.5 26 15 .8 .4 + NIL Opc NIL NIL NIL 
3. 3265 Kavitha 35/F 10100 57 30 13 9600 53 39 8 10 22 7 15 9.0 13.4 29 15 .5 .4 + NIL Rbc NIL NIL NIL 
4. 4321 Ushanandhini 33/F 9000 57 39 4 9800 60 36 4 5 11 5 10 13.0 15.0 28 15 .2 .2 + NIL Opc NIL NIL NIL 
5. 646 Padmavathy 38/F 10200 62 33 5 10000 52 33 5 15 38 10 22 10.4 12.5 21 15 .4 .5 + NIL Opc NIL NIL NIL 
6. 7028 Perumal 21/M 9400 59 36 5 9800 60 36 4 15 5 11 30 12.4 15.0 24 15 .6 .4 + NIL Opc NIL NIL NIL 
7: 4489 Sornambigai 41/F 7800 56 38 6 10100 60 36 4 2 7 5 10 8.0 11.5 26 15 .8 .5 + NIL                 Rbc NIL NIL NIL 
8. 1590 Shyamala 40/F 9800 59 36 5 10200 60 34 6 3 6 5 10 16.0 12.4 28 15 .5 .4 + NIL Opc NIL NIL NIL 
9. 8228 Rajendran 38/M 9S0O 59 37 4 8900 55 41 4 15 20 5 12 13.0 12.0 29 15 .2 .2 + NIL Opc NIL NIL NIL 
10. 8227 Natarajan 43/M 10200 60 34 6 10400 60 36 4 5 11 25 60 13.0. 12.5 30 15 .4 .4 + NIL Epc NIL NIL NIL 
11 9845 Velappan 29/M 10400 60 34 6 9600 50 45 5 8 25 12 25 13.0 15.0 32 20 .6 .5 + NIL Opc NIL NIL NIL 
12. 7310 Ramesh 32/M 9100 57 38 5 9800 60 34 6 5 20 15 33 11.2 8.0 26 20 .8 .4 + NIL Opc NIL NIL NIL 
13. 1650 Sureshbabu 32/M 9700 57 38 5 9200 55 41 4 5 12 5 11 12.0 12.0 20 20 .5 .4 + Nil Epc NIL NIL NIL 
14. 3288 Pandurangan 31/M 9800 57 39 4 9400 57 38 5 12 13 10 18 10.0 13.4 29 20 .2 .2 + NIL Opc NIL NIL NIL 
15. 1656 Anusha 24/F 9700 59 33 8 9700 69 33 8 5 13 8 18 12.6 12.6 30 20 .4 .4 + NIL Opc NIL NIL NIL 
16. 9539 Balaji 20/M 10000 57 38 5 9000 54 42 4 5 12 5 7 16.0 13.0 32 25 .6 .5 + NIL Rbc NIL NIL NIL 
17. 4553 Deenadayalan 48/M 9000 53 40 7 10200 61 35 4 9 25 7 12 10.0 12.0 28 25 .8 .5 + NIL Opc NIL NIL NIL 
18. 4517 Megala 43/F 10400 66 28 6 10100 60 36 4 7 16 10 15 12.0 14.5 26 25 .5 .4 + NIL Epc NIL NIL NIL 
19. 306 Beermaideen 48/M 9000 54 42 4 9800 56 41 3 2 8 5 11 12.0 15.0 24 25 .2 .2 + NIL Opc NIL NIL NIL 
20. 5717 Karpagam 29/F 9400 55 41 4 9500 61 35 1 2 4 5 ' 10 12.5 14.0 25 25 .4 .4 + NIL Opc NIL NIL NIL 
21. 9753 John Martin 60/M 9000 55 38 7 10500 62 34 4 22 45 15 30 9.0 12.5 27 20 .6 .5 + NIL Opc NIL NIL NIL 
22. 5930 Sridhar 31/M 9400 59 36 5 10100 62 34 4 5 12 4 7 11.8 13.5 26 20 .8 .6 + Nil Opc NIL NIL NIL 
23. 9776 Jagannathan 55/M 10100 57 30 13 9600 53 39 8 10 22 7 15 9.0 13.4 21 20 .5 .5 + NIL Rbc NIL NIL NIL 
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SL.  
No. 
 
 
 
 
O.P.  
No. 
 
 
 
 
Name 
 
 
 
 
Age/Sex 
 
 
 
 
HAEMATOLOGICAL REPORT  URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT ESR (mm) Hb (Gm) Urea Creatinine BT AT 
TC  
CU/ 
mm 
 
 
DC% TC 
CU/ 
m m 
 
 
 BT AT BT AT BT AT BT AT Alb Sug Dep Alb Sug Dep 
P L E P L E 1/2 hr 
1 
hr 
½ 
hr 
1 
hr 
 
 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
24. 285 Azharudeen 25/M 9000 57 39 4 9800 60 36 4 5 11 5 10 13.0 15.0 30 20 .2 .2 + NIL Opc NIL NIL NIL 
25. 7368 Santhosh 37/M 10200 62 33 5 10000 52 33 5 15 38 10 22 10.4 12.5 32 20 .4 .4 + NIL Opc NIL NIL NIL 
26. 958 Radhakrishnan 48/M 9400 59 36 5 9800 60 36 4 15 5 11 30 12.4 15.0 34 18 .6 .5 + NIL Opc NIL NIL NIL 
27. 6115 Pushparaj 60/M 7800 56 38 6 10100 60 36 4 2 7 5 10 8.0 11.5 25 18 .8 .4 + NIL        Rbc NIL NIL NIL 
28. 4328 Yegiyakhan 38/M 9800 59 36 5 10200 60 34 6 3 6 5 10 16.0 12.4 27 18 .5 .4 + NIL Opc NIL NIL NIL 
29. 6605 Ponpandiyan 22/M 9S0O 59 37 4 8900 55 41 4 15 20 5 12 13.0 12.0 20 18 .2 .2 + NIL Opc NIL NIL NIL 
30. 5763 Balasubramani 40/M 10200 60 34 6 10400 60 36 4 5 11 25 60 13.0. 12.5 28 18 .4 .4 + NIL Epc NIL NIL NIL 
31. 6323 Madhan 20/M 10400 60 34 6 9600 50 45 5 8 25 12 25 13.0 15.0 26 18 .6 .5 + Nil Opc NIL NIL NIL 
32. 4155 Elumalai 30/M 9100 57 38 5 9800 60 34 6 5 20 15 33 11.2 8.0 24 18 .8 .6 + NIL Opc NIL NIL NIL 
33. 4826 Dhachayini 45/F 9700 57 38 5 9200 55 41 4 5 12 5 11 12.0 12.0 25 18 .5 .4 + NIL Epc NIL NIL NIL 
34. 6603 Venkatesan 47/M 9800 57 39 4 9400 57 38 5 12 13 10 18 10.0 13.4 27 18 .2 .2 + NIL Opc NIL NIL NIL 
35. 430 Annadurai 37/M 9700 59 33 8 9700 69 33 8 5 13 8 18 12.6 12.6 26 17 .4 .4 + NIL Opc NIL NIL NIL 
36. 2358 Kennadiraja 44/M 10000 57 38 5 9000 54 42 4 5 12 5 7 16.0 13.0 28 17 .6 .5 + NIL Rbc NIL NIL NIL 
37. 4210 Paramasivam 42/M 9000 53 40 7 10200 61 35 4 9 25 7 12 10.0 12.0 26 17 .8 .5 + NIL Opc NIL NIL NIL 
38. 6608 Ganesh 33/M 10400 66 28 6 10100 60 36 4 7 16 10 15 12.0 14.5 24 15 .5 .4 + NIL Epc NIL NIL NIL 
39. 7788 Senthil 32/M 9000 54 42 4 9800 56 41 3 2 8 5 11 12.0 15.0 25 15 .2 .2 + NIL Opc NIL NIL NIL 
40. 4572 Ramani 48/F 9400 55 41 4 9500 61 35 1 2 4 5 10 12.5 14.0 27 15 .4 .4 + NIL Opc NIL NIL NIL 
 
    TC – Total Count,  Hb – Hemoglobin, Dc – Differential Count, P – Polymorph, L – Lymphocyte, E – Eosinophil, ESR – Erythrocyte Sedimentation Rate, OEC 
– Occasional Epithelial Cells, OPC – Occasional Pus Cells, Rbc – Eed blood cell, Alb – Albumin,  Sug – Sugar, Dep - Deposits 
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EXPELLED STONES 
Name:  Azharudeen – 25 / M  
 
 
Name:  Paramasivam – 42 / M  
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Name:  Ramesh – 33 / M  
 
 
Name:  Surendar – 46 / M  
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DISCUSSION 
 ‘KALLADAIPPU’ is a common disease pertaining to the kidney. Large 
population are suffering from this disease. But they are not completely relieved 
from their symptoms by other systems of medicine. Hence with the help of trial 
medicine from siddha system, results and observations are noted for this study. 
 The patients were examined based on siddha and as well as modern aspects. 
All the necessary investigations were made during the study. The results 
obtained from their studies were discussed below for better conclusion. 
 Trial medicine administered was, 
 Megarajanga chooranam - 1gm 2 times/day 
 With butter after food for 48 days. 
1.Sex distribution: 
 Among 40 cases 30 were males and 10 were females. 
2.Age distribution: 
 Although all the decades of people are affected 37.5% were affected in 3rd 
decade, 25% were in 2nd decade. 
3.Occupation: 
 Mixed categories of people are affected, from housewife to working woman, 
students to retired person. Among the total, 30 males, 20 are mechanics and 
office workers. In overall occupational distribution also they occupy the first 
place and next comes manual workers and students. 
4.Food Habits: 
 All of my patients were having mixed dietary habits, eat both vegetarian and 
non vegetarian food. 
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5.According to season: 
 The highest incidence were noted in Elavenir Kaalam and 22.5% cases were 
noted in munpani kaalam. This shows that due to hot climate, majority of the 
people have been reported during this period. 
6.Distribution of Thinai 
 According to thinai the highest distribution 80% was noted in neithal and 20% 
was noted in Kurinchi. 
7.On clinical manifestations 
 All of my patients were present one or more urinary symptoms, 95% were 
having loin pain, 77.5% were having burning micturition, 40% had dysuria, 
30% had nausea, 12.5% had vomiting, 7.5% had haematuria and 1 patient had 
fever and retention. 
8.Mukkutram: 
 Disturbance of vatham: 
 Among the patients 100% were affected in Abanan and Viyanan, 32.5% in 
Uthaman, 20% in samanan and 30% in Kirukaran. 
 Affected Abanan produce burning micturition, constipation and haematuria. 
 Affected viyanan produced tenderness from loin and groin. 
 Affected samanan produce loss of appetite, indigestion and flatulence. 
 Affected uthaman produce nausea, vomiting 
 Affected koorman produce nausea 
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Disturbance of pitham: 
 Among the treated patients, 100% were affected in sathaga pitham, 22.5% were 
affected in ranjagapitham, 20% were affected in anarpitham. 
 The affected anarpitham produced loss of appetite. Affected Ranjagapitham 
produced pallor of skin, eye, nail and reduced haemoglobin. 
 Affected sathagapitham produce difficulty in doing our routine work. 
Disturbance of kabam 
 7.5% were affected by pothagam. 20% were affected in Klethagam. 5% were 
affected by santhigam. 
 Distributed Klethagam produces loss of appetite. Affected santhigam produces 
low back pain, knee joint pain, affected pothagam produces decreased taste 
sensation. 
9.Ezhu udal Thathukkal 
 In this heading 100% of patients are suffered from tiredness and 22.5% are 
having anemia. 
10. Enn vagai Thervugal – NAADI 
 In this, on examination of naadi, 37.5% are having vathapitham naadi and 50% 
are having pithavatha naadi and 12.5% are having kabhapitha naadi. A seat 
anchor of Azhal is urinary bladder. The trial drugs balance the impaired azhal 
and treats the urinary symptoms. 
11. Neikuri 
 On neikuri examination 57.5% were having pitha neer. 27.5% were having 
vatha neer and 15% were having kabaneer. 
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 A drop of gingely oil dropped into the early morning urine sample in a bowl, 
may result in, spread like snake-called vatham, like a ring in pitham, like pearl 
in kabam. 
12. Urinary calculi based on site 
 In total 40 patients 23 were having bilateral stones (57.5%), 22.5% right side 
stones and left side is 20%. 
13. Urinary calculi based on location 
 Most of the patients 36 (90%) were reported with renal calculi and only 2 
patients – 5% were with ureteric calculi and vesical calculi. 
 This shows that the ureteric calculi are easily pushed out by Allopathic 
treatments and the people with calculi in the kidney approaches siddha system 
for a permanent relief. 
14. Special Investigation: 
 USG – abdomen, and pelvis is advised for all the patients, to confirm the 
diagnosis. 
 After confirming the diagnosis, the patients were given the trial medicine and 
instructed to follow the diet and other restrictions based on Siddhasystem. 
15. Urine Analysis: 
 It was observed that, 80% of cases showed PUS cells in urine. 
  
108 
 
16. Mode of action of the drug 
 According to Siddha system. 
Based on Suvai: 
 The trial medicine Megarajanga chooranam has sweet taste. This taste will 
mitigate the vitiated pitham which is the main cause for Kalladaippu. This 
medicine act against the vitiated pitham. So it is considered as Ethirurai 
Maruthuvam. 
Based on Veeriyam: (Nature) 
 The trial medicine Megarajanga chooranam possess Thatpa Veeriyam. So it 
cures pitha diseases. 
 By this Megarajanga chooranam treats Kalladaippu Noi. 
Based on Adjuvant action: 
Megarajanga chooranam is given with Butter which corrects pitha 
dearrangement. 
19. Phytochemical Analysis  
 Megarajanga chooranam has sulphide, copper, iron, potassium, magnesium, 
alkaloids, reducing sugar. 
 In this potassium, magnesium and sulphate have diuretic actions. 
20. Toxicological analysis 
 Acute and subacute toxicity studies were conducted at Veltech College of 
Pharmacy. At the end of toxicity studies the animals were sacrificied and the 
hematological parameters (TC, DC and Hb), Biochemical parameters (LFT, 
KFT) and histopathology of vital organs like Liver, Kidney, Spleen and Lungs 
were carried out. 
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21. Pharmacological analysis 
 Pharmacological studies of the trial medicine Megarajanga chooranam showed 
Urolithiatic and diuretic actions in albino wistar rats. 
 The results of preclinical screening, the results of Chemical analysis, 
Toxicological studies, Pharmacological studies are shown in annexures. 
22. Statistical Analysis 
 The preclinical studies of trial medicine Megarajanga chooranam statistically 
analysed and showed significant result. 
 Statistical analysis of clinical study were done for the subjective and objective 
parameter, observed before and after treatment statistical results of preclinical 
and clinical study were attached to annexure. 
23. Results after treatment 
 Many of my patients were relieved of their problem, 50% showed good result 
that is both by symptoms and by X-Ray and sonographic findings, 42.5% 
showed fair result who are relieved of their symptoms but having stones 
sonographically, 3 patients that is 7.5% were not relieved of their problem. 
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SUMMARY 
 I like to summarize this study with the following highlights. 
 Males are more prone to get kalladaippu than females according to my 
studies. 
 In age distribution, 3rd and 4th decades of people are more affected 
 Housewifes and manual workers occupy the first two places in 
occupational classification 
 All of my patients, had mixed dietary habits 
 Higher incidence of cases were noted in Elavenir kaalam (April – June) 
 In the disturbance of Ezhu udal thathukkal, 100% were affected by 
saaram, 22.5% were affected by senneer and 5% were affectedby Enbu. 
 In Naadi, most of the patients were having pitha vadha naadi and 
vadhapitha naadi 
 In Neikuri examination 57.5% were having pithaneer 
 All of my patients were having urinary presentation, 95% were having 
loin pain, 77.5% had burning micturition, 40% had dysuria. 30% had 
nausea, 12.5% had vomiting, 7.5% had retention and haematuria. 
 Most of the 40 patients, had stone in kidney (ie) Bothsides of urinary 
system is affected in majority of 57.5% 
 All of my patients were administered with my trial medicine 
Megarajanga chooranam – 1 gm bd with butter after food for a period of 48 
days. 
After treatment with this trial medicine most of the symptoms like loin pain, 
burning micturition and dysuria are relieved by the expulsion of the stone. 
And the trial medicine shows 62.5% good result. 
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CONCLUSION 
 Kalladaippu is a common disorder of Pithakuttram. The dearranged 
pitham is settled down by the trial medicine having suvai Inippu thereby 
the medicine acts as Ethirurai maruthuvam to cure the disease. 
 Most of the cases noted in kaarkalam, ilavenir kaalam in my clinical 
trial. So, people should take all preventive measures during this period 
and take enough water. 
 Toxicological studies showed no acute or subacute toxicity. 
 Pharmacological study reveals that the trial medicines possess diuretic 
as well as lithotriptic actions. 
 During the clinical trial, no adverse reactions or complications were 
observed. 
 The palatability of the trial drug is sweet, so it is easier to consume to 
the patients. 
 The trial medicine Megarajanga chooranam showed good results with 
the expulsion of stone in few patients and relieve urinary symptoms in 
almost 90% of patients. 
 Once again siddha medicine proves itself as a great boon to mankind. 
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ANNEXURE – 1 
 
PHYTO - CHEMICAL ANALYSIS 
CHEMICAL ANALYSIS OF TRIAL MEDICINES 
 
Preparation of Sodium Carbonate extract 
2gm of Trial medicine Megarajanga choornam - is weighed accurately and 
mixed with 5gm of sodium carbonate taken in a 100ml beaker and 20ml of 
distilled water is added. The solution is boiled for 10 minutes, cold and then 
filtered. The filterate is called sodium Carbonate extract. 
S. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
1. TEST FOR ACID RADICALS   
a) Test for Sulphate 
2 ml of the above prepared extract is taken 
in a test tube. To this add 2 ml of 4% 
Ammonium oxalate solution. 
 
- 
- 
b) 2 ml of extract is added with 2 ml of dilute 
Hydrocholoric acid until the effervescence 
ceases off. Then 2 ml of Barium chloride 
solution is added. 
A white precipitate 
develops 
Present 
2. Test for Chloride 
2 ml of extract is added with dilute Nitric 
acid till the effervescence ceases. Then 2 
ml of silver Nitrate solution is added. 
Cloudy appearance 
develops 
Presence of  
Chloride 
3. Test for Phosphate 
2 ml of the extract is treated with 2 ml of 
Ammonium Molybdate solution and 2 ml 
of concentrated Nitric Acid. 
Cloudy appearance 
develops 
Presence of 
phosphate 
4. Test for Carbonate 
2 ml of the extract is treated with 2 ml of 
Magnisium Sulphate solution. 
- - 
5. Test for Sulphide 
1 gm of the substance is treated with 2 
ml of concentrated Hydrocholric acid 
Absent Absent 
6. Test for Nitrate 
I gm of the substance is heated with 
copper turnings and concentrated 
Suophuric acid and viewed the test tube 
vertically down. 
Absent Absent 
7a. Test for Fluoride and Oxalate 
2 ml of the extract is added with 2 ml of 
dilute Acetic acid and 2 ml of Calcium 
Chloride solution and heated. 
Absent Absent 
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S. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
b. 5 drops of clear solution is added with 2 
ml of dilute sulphuric acid and slightly 
wanned. To this, 1 ml of dilute Potassium 
Permanganate solution is added. 
Present Present 
8. Test for Nitrite 
3 drops of the extract is placed on a filter 
paper. On that, 2 drops a Acetic Acid and 
2 drops of Benzidine solution is placed. 
Absent Absent 
9. Test for Borate 
2 pinches of the substance is made into 
paste by using Sulphuric acid and 
Alcohold (95%) and introduced into the 
blue flame. 
Absent Absent 
II. TEST FOR BASIC RADICALS 
10. Test for lead 
2 ml of the extract is added with 2 ml of 
Pottassium Iodide solution 
Absent Absent 
11a Test for Copper 
One pinch of substance is made into paste 
with concentrated Hydrochloric acid in a 
watch glass and introduced into the non 
luminous part of the flame. 
Absent Absent 
b. 2ml of the extract is added with excess 
of Ammonia solution 
Absent Absent 
12. Test for Aluminium 
To the 2nd ml of extract. Sodium 
Hydroxide solution is added in drops to 
excess. 
Absent Absent 
13a Test for Iron 
To the 2nd ml of extract, 2 ml of 
Ammonium Thiocyanate solution is 
added. 
Present Present 
b. To the 2nd ml of extract, 2 ml of 
Ammonium Thiocyanate solution and 2 
ml of concentrated Nitric Acid is added. 
Present Present 
14. Test for Zinc 
To the 2 ml of extract Sodium Hydroxide 
solution is added in drops to excess. 
A white precipitate 
appears 
Present 
15. Test for Calcium 
2 ml of the extract is added with 2 ml of 
4% Ammonium Oxalate solution. 
Absent Absent 
16. Test for Magnesium 
To 2ml of extract, Sodium Hydroxide 
solution is added in drops to excess. 
A white precipitate 
appears 
Present 
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S. 
NO 
EXPERIMENT OBSERVATION INFERENCE 
17. Test for Ammonium 
To 2 ml of extract few ml of Nessler's 
Reagent and excess of Sodium Hydroxide 
solution are added. 
- - 
 
18. Test for Potassium 
A pinch of substance is treated with 2 ml 
of Sodium Nitrite solution and 
then treated with 2 ml of Cobal Nitrate in 
30% glacial Acetic acid. 
Yellow precipitate 
forms 
Present 
19. Test for Sodium 
2 pinches of the substance is made into 
paste by using Hydrocholoric acid and 
introduced into the blue flame. 
Yellow color flame 
appears 
Absent 
20. Test for Mercury 
2 ml of the extract is treated with 2 ml of 
Sodium Hydroxide solution. 
Absent Absent 
 
 
21. Test for Arsenic 
2 ml of extract is treated with 2 ml of 
silver Nitrate solution 
Absent Absent 
 
The given sample contains 
 
ACID RADICALS 
1. Megarajanga Choornam 
• Sulphate 
• Phosphate 
   
BASIC RADICALS 
1. Megarajanga Choornam 
• Ferrous Iron 
• Copper 
• Potassium 
• Magnesium 
 
Diuretics: 
  Potassium, Copper, magnesium and sulphide 
 
Lithotriptic 
 Potassium and magnesium. 
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ANNEXURE - 2 
ANTIUROLITHIATIC ACTIVITY OF MEGARAJANGA CHOORANAM IN 
ETHYLENE GLYCOL INDUCED LITHIATIC RATS 
INTRODUCTION 
 Nephrolithiasis is common, affecting up to 10% of the population at some 
point during their lifetime. Calcium-containing stones are the most commonly 
occurring to an extent of 75-90% followed by magnesium ammonium 
phosphate to an extent of 10-15%, uric acid 3-10% and cystine 0.5-1%. 
Calcium oxalate stones are found in two different varieties, calcium oxalate 
monohydrate or calcium oxalate dihydrate. Calcium oxalate monohydrate, the 
thermodynamically most stable form, is observed more frequently in clinical 
stones than calcium oxalate dihydrate and it has a greater affinity for renal 
tubular cells, thus responsible for the formation of stones in the kidney.  
 Oxalate, a metabolic end product and a major constituent of the majority of 
renal stones, has been shown to be toxic to renal epithelial cells of cortical 
origin. It has been observed that exposure of renal epithelial cells to oxalate 
which is a constituent of most kidney stones leads to a disruption of the normal 
activities of the renal epithelial cells such as altered membrane surface 
properties and cellular lipids, changes in gene expression, disruption of 
mitochondrial function, formation of reactive oxygen species and decreased 
cell viability. Various mechanisms have been proposed to explain crystal 
retention. As a result of crystal growth and agglomeration, particles may be 
formed that are too large to freely pass the renal tubules. Alternatively, 
relatively small crystals could be retained by adhering to the surface of the 
urothelial lining and then increase in size. The surgical methods available to 
treat kidney stones like extracorporeal shock wave lithotripsy have serious side 
effects. Therefore, it is worthwhile to look for an alternative for the 
management of urolithiasis. Urolithiasis is the third most common disorder of 
the urinary tract, the others being frequently occurring urinary tract infections 
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and benign prostatic hyperplasia. The worldwide incidence of urolithiasis is 
quite high and in spite of tremendous advances in the field of medicine, there is 
no truly satisfactory drug for the treatment of renal calculi.  
 Siddha system plays a vital role in providing plant based medicines to 
overcome this disease. Kidney oxalate stone is the result of supersaturation of 
urine with certain urinary salts such as calcium oxalate. The supersaturation of 
urine with CaOX(Calcium oxalate), the most common component of kidney 
stones, is an important factor in crystallization, with later factors being 
nucleation, growth and aggregation.  
 Megarajanga Chooranam has been studied initially for diuretic property. 
Generally, drugs having diuretic activity are also known to have antiurolithiatic 
activity. Hence in the present study, an effort has been made to evaluate the 
antiurolithiatic activity of Megarajanga Chooranam using ethylene glycol 
induced lithiasis in rats. 
MATERIALS AND METHODS 
Preparationofdrugandstocksolution
 The suspension of siddha drug Megarajanga Chooranamin 2%(w/v) CMC was 
prepared for oral administration by gastric intubation method. 
Animalselection
 For acute toxicity studies, Wistar albino mice of either sex weighing between 
28 and 30 g were selected. For the antiurolithiatic study, male Wistar weighing 
between 180-220 g were used. The animals were acclimatized to standard 
laboratory conditions (temperature: 25±2°C) and maintained on 12-h light: 12-
h dark cycle.  They were provided with regular rat chow and drinking water ad 
libitum. (Approval number: XIII/VELS/PCOL/19/ 2000/CPCSEA/IAEC/ 
08.08.2012). 
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Acute toxicity studies 
 The acute oral toxicity study was carried out as per the OECD guidelines 425. 
One-tenth of the median lethal dose was taken as an effective dose. 
Ethyleneglycolinducedurolithiasismodel
 Ethylene glycol induced urolithiatic model in rat was be used to assess the 
effect of Megarajanga Chooranam. The study is designed to find out the effect 
of Megarajanga Chooranam on therapeutic usage against ethylene glycol 
induced urolithiasis. All rats were housed in metabolic cages for entire duration 
of the experiment. Animals were divided into five groups containing six 
animals in each.  Group I served as control and received regular rat food and 
drinking water ad libitum.  Ethylene glycol (0.75%) in drinking water was fed 
to Groups II-V for induction of renal calculi till 28th day.  Group II received 
Ethylene glycol alone and served as urolithiatic control. Group III received 
standard antiurolithiatic drug, cystone (750mg/kg body weight) from 15th day 
till 28th day.  Groups IV received Megarajanga Chooranam (50mg/kg body 
weight) from 15th day till 28thday, Group V received Megarajanga 
Chooranam(100mg/kg body weight) from 15st day till 28th day.   
Group and Treatment 
Group 1: Treated with Normal saline 
Group 2: Treated with Control (ethylene glycol) + vehicle 
Group 3: Treated with Standard (ethylene glycol + Cystone) 
Group 4: Teated with Megarajanga Chooranam (50mg/kg) + ethylene glycol 
Group 5: Treated with Megarajanga Chooranam(100mg/kg) + ethylene glycol 
All doses were given once daily by oral route. 
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Assessment of antiurolithiatic activity 
Collection and analysis of urine: 
 All animals were kept in individual metabolic cages and urine samples of 24h 
were collected on 28th day.  Animals will be having free access to drinking 
water during the urine collection period.  A drop of concentrated hydrochloric 
acid was added to the urine before being stored at 4°C.  Urine was analyzed for 
calcium, phosphate and oxalate content. 
Serum Analysis: 
 After the experimental period, blood was collected from the retro-orbital vein 
under anesthetic conditions and animals were sacrificed by cervical 
decapitation.  Serum was separated by centrifugation at 10,000x g for 10 min 
and analyzed for creatinine, uric acid and urea nitrogen. 
Kidney homogenate analysis: 
 The abdomen was cut open to remove both kidneys form each animal.  Isolated 
kidneys were cleaned off extraneous tissue and preserved in 10% neutral 
formalin.  The kidneys were dried at 80°C in a hot air oven.  A sample of 
100mg of the dried kidney were boiled in 10ml of 1N hydrochloric acid for 
30min and homogenized.  The homogenate was centrifuged at 2000x g for 
10min and the supernatant was separated.  The calcium, phosphate and oxalate 
content in kidney homogenate were determined. 
DIURETIC ACTIVITY: 
Standarsization Of Furosemide   
 Seven groups of six male wistar albino rats were employed four doses of 
10,15,20,25-mg/kg b.w of furosemide were administered intraperitoneaaly to 
each group of rats separately.  The control animals received normal saline 
alone. The animals were placed in separate cages and the urine output over 
24hr period was collected. This procedure was repeated. The most consistent 
dose (15mg/kg b.w) was adapted for dosing.  
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Evaluation of diuretic activity 
 Five groups of six male Wistar albino rats were used. First group received 
normal saline.  Second group received Megarajanga Chooranam 50mg/kg.  The 
third group received Megarajanga Chooranam 100mg/kg. The fourth group was 
administered furosemide 20mg/kg.  Immediately after administration of the 
drug, the rats were placed in metabolic cages, specially designed to separate 
urine and fecal matter and was observed at room temperature. The animals 
were denied for food and water during the experiment. The urine volume 
(ml/day) was measured and then assayed for Na+ and K+ and Cl- concentrations 
in mMol/l, Cl was measured using routine method. 
Statistical analysis: 
 Results expressed as mean ± S.E.M.  Differences among data was determined 
using one-way ANOVA followed by Dunnet ‘t’test.  
RESULTS AND DISCUSSION 
 Ethylene glycol induced urolithiasis resulted in significant elevation of urine 
and kidney calcium, oxalate, inorganic phosphate and serum blood urea 
nitrogen, creatinine, uric acid compared to normal control group. Treatment 
with cystone (750 mg/kg) and Megarajanga Chooranam reduced the bio-
chemical changes induced by ethylene glycol. In order to probe the possible 
mechanism by which Megarajanga Chooranam cures renal damage caused by 
ethylene glycol, investigation on levels of various stone inhibitors like total 
protein, magnesium and citrate was studied. There was significant rise on total 
protein, magnesium and citrate after treatment with cystone and Megarajanga 
Chooranam. 
 Administration of ethylene glycol significantly reduced the body weight, urine 
volume and pH of urine as compared to normal group. Rats treated with 
cystone and Megarajanga Chooranam also showed significant decreased in 
body weight, urine volume and pH of urine as compared to control group. The 
histopathological study of the kidney sections also supported the above results. 
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In all the stone forming rats there was damage to the last part of the nephron, 
collecting system and peritubular interstitium as compared to the normal rat 
kidney architecture. The tubules appeared focally ecstatic and surrounded by 
inflammatory infiltration.  
 Flattened epithelium with focal vacuolar degeneration and single cell necrosis 
bordered the tubules, which focally contained hyaline casts. Inflammatory 
infiltration was mainly composed of mature lymphocytes infiltrating tubular 
epithelium. Irregular crystals were present inside the tubules and in the 
peritubular interstitium, along the nephron and at papillary level. The 
Megarajanga Chooranam treated groups showed normal histology of the 
kidney, and shows normal glomeruli, slight oedema of the tubular cells 
compared to standard drug treated animals. The kidneys excised from ethylene 
glycol treated group were larger and heavier than from the control animals. 
When observed under light microscope, many crystalline deposits in the 
histological preparations were seen in tubules of all regions of kidney.  
 In Megarajanga Chooranam along with EG treated rats, such deposits were 
small and less abundant. Microscopic examination of kidney sections derived 
from EG induced urolithiatic rats showed calcification inside the tubules which 
causes dilation of the proximal tubules. Co-treatment with Megarajanga 
Chooranam decreased the calcification in different parts of therenal tubules and 
also prevented damages to the tubules and calyxes. Organ-body weight ratio is 
amarker of cell constriction and inflammation. The non-significant effect on 
the rat kidney-bodyweight ratio following the administration of various doses 
of the Megarajanga Chooranam suggests that the drug did not induce 
inflammation or constriction of the kidney cells.  
 Pathologic studies have shown that the renal failure from EG is associated with 
proximal tubule cell necrosis leading to production of several metabolites 
(glycol aldehyde, glycolate, glyoxylate and oxalate, in that order) and 
accumulation of large calcium oxalate monohydrate crystals in tubular lumen.  
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 An Ayurvedic compound preparation (Cystone) was found to contain water 
solublesubstances, which inhibited the initial precipitationof calcium and 
phosphate ions in the form of a mineral phase bound to the organic matrix and 
the subsequent growth of the preformed mineral phase.In the present study, 
concurrent administration of EG with cystone / Megarajanga Chooranam 
causes significant curative effect in EG induced changes. The effect is dose 
dependent. The effectiveness of Megarajanga Chooranam is comparable to 
cystone.  
 Renal Stone denotes stones originating anywhere in the urinary tract, including 
the kidneys, ureters and bladder. The formation of stones in the urinary tract 
affects 5–10% of the population in Europe and North America. In most 
populations the occurrence of urolithiasis in men is two to three times higher 
than in women as testosterone enhances whereas estrogen inhibits calcium 
oxalate stone formation. The formation of calcium oxalate stone is a multi-step 
process and includes–nucleation, crystal growth, crystal aggregation and crystal 
retention which further result in precipitation of certain substances within 
urine. This process is favored in the presence of a supersaturated milieu which 
is necessary for precipitating crystal.  Thus supersaturation acts as a driving 
force for stone formation. Additionally another theory of stone formation was 
identified and concluded as an imbalance between promoter (calcium, oxalate, 
uric acid, inorganic phosphate etc) and inhibitors (citrates, magnesium, 
potassium, pyrophosphate and urinary glycoprotein etc).  
 Furthermore, reactive oxygen species or free radicals (species with one or more 
unpaired electrons) generated due to oxidative stress, damages epithelium of 
kidney or bladder, thereby producing a favorable environment for crystal 
attachment to surface. As a result of these, the stone may not be able to travel 
through the ureter, causing pain and possibly an obstruction, blocking the flow 
of urine out of the kidney. Severe pain or aching in the back on one or both 
sides, sudden spasms of excruciating pain, bloody, cloudy or smelly urine, 
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feeling of being sick, a frequent urge to urinate, or a burning sensation during 
urination, fever and chills, etc are commonly observed symptoms in the 
patients. Patients suffering from diseases like hyperparathyroidism, renal 
tubular acidosis, cystinuria, hypercalciuria, hyperoxaluria, crohn’s disease etc. 
are more prone to stone formation.  
 The renal tissue of EG along with Megarajanga Chooranam shows only few 
stray areas of calcification in glomeruli and normal tubular structures with no 
congestion in blood vessels. The renal tissue of standard drug treatment still 
shows moderate calcification in many tubules and few glomeruli. It has been 
reported that the kidneys are the principle target organfor ethylene glycol 
toxicity and administration of ethylene glycol for 3 weeks resulted in 
insignificant urinary oxalate excretion and deposition of crystals in kidney, 
hence in our study ethylene glycol was chosen to induce lithiasis. Following 
the induction of lithiasis the urinary volume and composition were found to be 
altered.  
 In our study also the urinary output was markedly decreased in lithiatic control 
rats on day 28, however in Megarajanga Chooranam and standard treated rats 
the urinary volumes were increased when compared to that lithiatic Group. 
This suggested that Megarajanga Chooranam might have moderate diuretic 
effect. Following ethylene glycol administration the excretion of calcium, 
oxalate, phosphate and protein were found to be increased in lithiatic group 
while in standard, test groups these levels were significantly decreased 
(P<0.01). 
 On contrary to this the magnesium level was decreased in lithiatic group while 
in standard and Megarajanga Chooranam treated groups those levels were 
increased significantly (P<0.01). The serum creatinine levels of Megarajanga 
Chooranam treated rats restored to normal limits and the creatinine clearance 
was also found to be improved. The findings of the histopathological studies 
suggested that no microcrystalline deposition and kidney damage in the 
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Megarajanga Chooranam treated groups. All these observations enabled us to 
confirm the inhibitory potential of Megarajanga Chooranam on ethylene glycol 
induced lithiasis. 
CONCLUSION  
 The presented data indicate that administration of the Megarajanga Chooranam 
to rats with ethylene glycol induced lithiasis reduced the formation of urinary 
stones, supporting clinical information regarding antiurolithiatic activity of the 
Megarajanga Chooranam. The mechanism underlying this effect is still 
unknown, but is apparently related to diuresis and lowering of urinary 
concentrations of stone forming constituents. These effects could conclude the 
antiurolithiatic property of Megarajanga Chooranam. 
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Table 1: Diuretic activity of MegarajangaChooranam in rats 
 
Group Treatment 
and Dose 
Volume of 
Urine 
(ml/4hrs) 
Sodium 
(mMol/l) 
Potassium 
(mMol/l) 
Chloride 
(mMol/l) 
 
I Saline (10ml/ 
kg) 
0.82±0.15 74.7±5.3 65.4±4.2 91.2±6.4 
II MRC (250 mg/ 
kg) 
0.78±0.12b 88.0±6.9b 78.6±6.1c 110.8±10.1c 
III MRC (500 mg/ 
kg) 
1.12±0.15b 100.3±6.4c,* 89.2±5.8* 122.0±6.2* 
IV Frusemide (20 
mg/ kg) 
4.10±0.22** 125.1±4.8** 102.1±6.5** 142.7±8.8** 
 
All values are expressed as mean ±S.E.M for six rats in each group. 
Comparisons made between ***p<0.001; **p<0.01;*p<0.05 Vs control; ap<0.001; 
bp<0.01; cp<0.05 Vs Standard. 
 
 
 
Table 2: Estimation of Urinary Electrolytes of Normal and Urolithiatic Rats. 
S.No Group & Drug 
Treatment 
Estimation of Urinary Electrolytes 
Oxalate(mg/dl) Calcium(mg/dl) Phosphate(mg/dl) 
1 Normal control 
(Saline) 
0.35±0.05 2.66±0.12 3.21±0.03 
2 Calculi 
induced(0.75% EG) 
2.28±0.05©,x 8.17±0.36©,x 9.12±0.17©,x 
3 Standard (Cystone 
750 mg/kg) 
1.22±0.05x 3.19±0.20x 3.67±0.08x 
4  T1 (MRC250 mg/kg) 1.25±0.20*** 5.84±0.13a,*** 6.20±0.06a,*** 
5  T2 (MRC500 mg/kg) 0.76±0.12*** 4.33±0.12b,*** 4.98±0.13a,*** 
All values are expressed as mean ±S.E.M for six rats in each group. 
Comparisons made between 
ap<0.001,bp<0.01,cp,<0.05; T1,T2VsStandard. 
***p<0.001,**p<0.01,*p<0.05 ; T1,T2Vs Calculi induced. 
©p<0.001,Įp<0.01,@p<0.05; Calculi induced Vsnormal control. 
xp<0.001,yp<0.01,zp,<0.05; Calculi induced VsStandard., One-way ANOVA followed 
by Tukey test. 
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Table 3: Estimation of Kidney Homogenate Electrolytes of Normal And 
Urolithiatic Rats. 
S.No Group &Drug 
Treatment 
Estimation of Kidney Homogenate Parameters 
Oxalate(mg/dl) Calcium(mg/dl) Phosphate(mg/dl) 
1 Normal (Saline) 0.172±0.07 3.668±0.44 2.46±0.07 
2 Positive control (0.75% 
EG) 
1.742±0.09©,x 
 
6.12±0.22©,x 4.36±0.16©,x 
 
3 Standard (Cystone 750 
mg/kg) 
0.569±0.06x 
 
4.15±0.15x 3.05±0.10x 
 
4 T1 (MRC250 mg/kg) 1.156±0.09a,*** 
 
5.30±0.22c 
 
2.96±0.17*** 
 
5 T2 (MRC500 mg/kg) 0.768±0.08*** 4.19±0.16*** 2.67±0.08*** 
All values are expressed as mean ±S.E.M for six rats in each group. 
Comparisons made between 
ap<0.001,bp<0.01,cp,<0.05; T1,T2Vs Standard. 
***p<0.001,**p<0.01,*p<0.05 ; T1,T2Vs Calculi induced. 
©p<0.001,Įp<0.01,@p<0.05; Calculi induced Vsnormal control. 
xp<0.001,yp<0.01,zp,<0.05; Calculi induced VsStandard., One-way ANOVA followed 
by Tukey test. 
 
Table 4: Estimation of Serum Parameters of Normal and Urolithiatic Rats. 
S.No Group & Drug Treatment 
Estimation of Serum Parameters 
BUN (mg/dl) Creatinine (mg/dl) 
Uric acid 
(mg/dl) 
1 Normal (Saline) 20.31±0.28 0.702±0.06 4.86±0.07 
2 Positive control (0.75% 
EG) 
28.66±0.41©,x 0.924±0.07 6.93±0.10©,x 
3 Standard (Cystone 750 
mg/kg) 
23.91±0.32x 0.846±0.09x 5.26±0.08x 
4  T1 (MRC250 mg/kg) 26.81±0.52a,* 0.899±0.10 6.33±0.09a,*** 
5  T2 (MRC500 mg/kg) 24.35±0.40*** 0.828±0.12 6.00±0.11a,*** 
All values are expressed as mean ±S.E.M for six rats in each group. 
Comparisons made between 
ap<0.001,bp<0.01,cp,<0.05; T1,T2Vs Standard. 
***p<0.001,**p<0.01,*p<0.05 ; T1,T2Vs Calculi induced. 
©p<0.001,Įp<0.01,@p<0.05; Calculi induced Vsnormal control. 
xp<0.001,yp<0.01,zp,<0.05; Calculi induced VsStandard., One-way ANOVA followed 
by Tukey test. 
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HISTOPATHOLOGICAL STUDY OF TRIAL DRUGS 
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ANNEXURE - 3 
ACUTE AND SUB ACUTE TOXICITY STUDY ON  
MEGARAJANGA CHOORANAM  
Animals:  
 Mice of either sex weighing 25-30g and rats weighing 210-240g were obtained from 
the animal house of Vels University. The animals were used with the approval of the 
Institute animal ethics committee and obtained from Vels University, Chennai. They 
were fed with a balanced standard pellet diet and maintained under standard 
laboratory conditions, providing 24-280C temperature, standard light cycle (12 h light, 
12 h dark) and water ad libitum. Animals were kept in cages with raised floors of 
wide mesh to prevent coprophagy. Animal welfare guidelines were observed during 
the maintenance period and experimentation. The rats were randomly assigned to 
control  and  different  treatment  groups,  six  animals  per  group.  The  animals  were  
acclimatized for one week under laboratory conditions.  
ACUTE TOXICITY STUDY-OECD 425 GUIDELINES 
 Acute oral toxicity test for the Megarajanga Chooranam was carried out as per OECD 
Guidelines 425. As with other sequential test designs, care was taken to ensure that 
animals are available in the appropriate size and age range for the entire study. The 
test substance is administered in a single dose by gavage using a stomach tube or a 
suitable intubation cannula. The fasted body weight of each animal is determined and 
the dose is calculated according to the body weight. After the substance has been 
administered, food was withheld for a further 2 hours in mice. The animals were 
observed continuously for the first 4 h and then each hour for the next 24 h and at 6 
hourly intervals for the following 48 h after administering of the test drug, to observe 
any death or changes in general behaviour and other physiological activities. Single 
animals are dosed in sequence usually at 48 h intervals. However, the time interval 
between dosing is determined by the onset, duration, and severity of toxic signs. 
Treatment of an animal at the next dose was delayed until one is confident of survival 
of the previously dosed animal.  
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Observation of toxicity signs: General behavior, respiratory pattern, cardiovascular 
signs, motor activities, reflexes, change in skin and fur, mortality and the body weight 
changes were monitored daily. The time of onset, intensity, and duration of these 
signs, if any, was recorded.  
SUB-ACUTE TOXICITY  
 In a 28-days sub acute toxicity study, twenty four either sex (3+3) rats were divided 
into  four  groups  of  6  rats  each.  Group  I  that  served  as  normal  control  was  
administered with distilled water (p.o.) while groups II, III and IV were administered 
daily with the Megarajanga Chooranam (p.o.) for 28 days at a dose of 100, 250 and 
500mg/kg respectively. The animals were then observed daily for gross behavioural 
changes and any other signs of subacute toxicity. The weight of each rat was recorded 
on day 0 and weekly throughout the course of the study, food and water consumption 
per rat was calculated. At the end of the 28 days they were fasted overnight, each 
animal was anaesthetized with diethylether, following which they were then dissected 
and blood samples were obtained by cardiac puncture into heparinised tubes. The 
blood sample collected from each rat was centrifuged with 3000 X g at 4oC for 10 min 
to separate the serum and used for the biochemical assays.  
Hematological and blood biochemical analyses:  
 At the end of the study, all animals were kept fasted for 16-18 h and then anesthetized 
with anesthetic ether on the 28th day. Blood samples for hematological and blood 
chemical analyses were taken from retro orbital vein. Heparinized blood samples were 
taken for determining complete blood count (white blood cell count, differential white 
blood cell count, platelet count, red blood cell count, hematocrit, and hemoglobin) by 
semiautomated hematology analyzer. The serum from non-heparinized blood was 
carefully collected for blood chemistry and enzyme analysis creatinine, total protein, 
albumin, total and direct bilirubins, serum glutamate-oxaloacetate transaminase 
(SGOT), serum glutamate pyruvate transaminase (SGPT), and alkaline phosphatase 
(ALP)) were automatically determined using autoanalyzer. 
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Necropsy:  
 All rats were sacrificed after the blood collection. The positions, shapes, sizes and 
colors of internal organs were evaluated. The Spleen, Testes, Pancrea, Lung, Liver, 
Brain, Heart, Stomach, Intestine, Bone, Ovary, and Kidney tissues were excised from 
all rats to visually detect gross lesions, and weighed to determine relative organs’ 
weights and preserved in 10% neutral formalin for histopathological assessment. The 
tissues were embedded in paraffin, and then sectioned, stained with haematoxylin and 
eosin and were examined microscopically. 
Statistical analysis 
 Values were represented as mean ± SEM. Data were analysed using one-way analysis 
of variance (ANOVA) and group means were compared using the Tukey-Kramer 
Multiple Comparison Test using GraphPad Instat-V3 software. P values < 0.05 were 
considered significant. 
RESULTS 
 Animals were not shown any significant toxic clinical signs during the dosing period 
of 28 days. All animals from control and all the treated dose groups survived 
throughout the dosing period of 28 days. Results of body weight determination of 
animals of control and different dose groups exhibited comparable body weight gain 
throughout the dosing period of 28 days. During dosing period, the quantity of food 
consumed by animals from different dose groups was found to be comparable and 
normal with that of control animals. Ophthalmoscopic examination of animals in 
control and test product– treated groups did not reveal any major and remarkable 
abnormality.   
 These tests conducted on the experimental animals at termination and recorded did 
not reveal any abnormalities. Urine analysis data of control group and treated group of 
animals determined in week 4 did not reveal any abnormalities. Mean Relative Organ 
Weights are found to be comparable and normal. Gross pathological examination of 
animals in control as well as the treated groups did not reveal any abnormalities. The 
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results of haematological investigations revealed no major changes in the values of 
different parameters investigated when compared with control; However, the increase 
or decrease in the values obtained was within normal biological and laboratory limits. 
Results of Biochemical investigations revealed normal.  
CONCLUSION 
 In the present study, no toxic effect was observed upto 500mg/kg of Megarajanga 
Chooranam treated via oral route over a period of 28 days. So, it can be concluded 
that the Megarajanga Chooranam can be prescribed for therapeutic use in human with 
the dosage recommendations of upto 500mg/kg. body weight p.o. 
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Table 1: Dose finding experiment and its behavioral Signs of Toxicity 
No 
Dose 
mg/
kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. 2000 + - - + - + - - - - - - - - - - - - - - 
2 5000 + - - + - + - - - - - - - - - - - - - - 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 
11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 15.Lacrimation 16. 
Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality 
   
 
Table 2. Body wt (g) of albino rats exposed to Megarajanga  
Chooranam for 28days 
Dose 
(mg/kg/ 
day) 
Days
1 7 14 21 28 
Control 123.45r8.05 125.56r6.00 124.25r5.00 128.05r5.14 132.62r5.15 
100 127.10r4.31 129.21r5.15 132.12r5.62 135.64r6.00 136.45r4.00 
250 124.26r6.44 128.13r6.88 131.15r5.10 134.18r5.15 137.30r6.11 
500 122.13r8.27 125.62r5.34 128.12r5.82 131.02r6.30 134.62r5.35 
 
Values are mean of 6 animals r S.E.M. (Dunnet's test). nsP>0.05..  
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Table 3. Food (g/day) intake of rats exposed to Megarajanga  
Chooranam for 28days 
Dose 
(mg/kg/ 
day) 
Days (gms/rats) 
1 7 14 21 28 
Control 44.13r2.82 44.65r2.15 45.42r2.30 45.46r2.42 48.48r3.00 
100 42.20r2.12 45.13r2.46 46.58r2.26 47.28r2.52 48.12r3.02 
250 40.32r2.10 44.19r2.59 45.68r2.52 45.62r3.18 46.10r3.00 
500 43.12r2.48 45.24r2.83 46.11r2.72 45.18r2.88 45.56r3.12 
 
Values are mean of 6 animals r S.E.M. (Dunnet's test). nsP>0.05.  
 
Table 4. Water (ml/day) intake of rats exposed to Megarajanga  
Chooranam for 28days 
 
Dose 
(mg/kg/da
y) 
Days(ml/rat) 
1 7 14 21 28 
Control 55.24r2.80 55.00r3.26 52.10r3.15 52.30r3.18 52.28r3.21 
100 55.19r2.42 55.20r3.41 45.20r4.02 46.10r3.00 40.50r2.82** 
250 48.72r2.81 48.12r3.77 42.72r3.34 44.15r2.91 45.12r3.22 
500 50.23r2.56 56.16r3.10 54.25r3.18 49.02r3.19 45.00r3.16 
 
Values are mean of 6 animals r S.E.M. (Dunnet's test). **P<0.01.  
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Table 5. Effect of treatment with Mega Rajanga Chooranam  
biochemical parameters 
Dose (mg/kg) Control 100 mg/kg 250 mg/kg 500 mg/kg 
Total Bilirubin 
(mg/dL) 
0.211r0.05 0.210r0.06 0.214r0.05 0.210r0.04 
Bilirubin direct 
(mg/dL) 
0.1r0.04 0.1r0.05 0.1r0.04 0.1r0.05 
ALP (U/L) 71.05±2.5 70.11±2.8 69.21±3.2 71.30±2.8 
SGOT (U/L) 73.10±2.6 74.12±2.5 72.10±3.0 75.22 ± 2.1 
SGPT(U/L) 81.4±3.2 82.10±3.0 82.12±2.7 80.21±2.2 
Total Protein(g/dl) 10.10r1.02 10.14r0.80 9.58r0.77 9.51r0.96 
Albumin(g/dl) 3.27r0.25 3.51r0.24 3.44r0.13 3.22r0.12 
Globulin(g/dl) 6.00r0.18 5.48r0.20 4.90r0.24* 4.62r0.31** 
Urea (mg/dL) 55.25r1.26 54.41r3.25 55.0r2.14 54.18r1.32 
Creatinine (mg/dL) 28.22±3.0 31.17±3.2 29.42±3.12 29.11 ± 3.0 
Uric acid (mg/dL) 1.6r0.10 1.6r0.12 1.6r0.16 1.6r0.10 
Na m.mol 142.10r4.22 141.0r3.15 142.10r4.02 141.10r3.46 
K m.mol 20.18r2.12 19.75r2.44 20.28r2.20 20.25r2.31 
Cl m.mol 100.52r4.18 101.00r5.54 100.99r4.00 102.16r4.08 
 
Values are mean r S.E.M. (Dunnet ’t' test). *P<0.05; **P<0.01 Vs control.. 
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Table 6. Hematological parameters after 28days treatment with  
Megarajanga Chooranam 
Parameter Control 100 mg/kg 250 mg/kg 500 mg/kg 
RBC (mm3) 8.10r0.45 7.55r0.44 8.14r0.46 8.40r0.54 
HB (%) 14.24r0.36 14.45r0.38 14.51r0.36 14.15r0.32 
Leukocyte 
(x106/mL) 
11.14r1.27 10.22r1.25 10.82r1.26 10.74r1.35 
Platelets 
(X105/µl) 
1.25±0.12 1.32±0.14 1.35±0.14 1.38±0.14 
MCV (g/l) 85.62±4.5 85.24±5.30 86.12±4.22 84.54±5.24 
Neutrophil (%) 54.22±3.18 52.12 ±3.22 50.46±3.0 51.22±3.6 
Lymphocytes (%) 44.12±1.28 45.10±3.2 45.65±3.2 45.11±3.2 
Eosinophil’s (%) 5.0±0.4 5.0±0.4 5±0.3 5±0.4 
Monocytes (%) 3.0±0.02 3.0±0.3 3.0±0.3 3.0±0.3 
Basophils (%) 0±0 0±0 0±0 0±0 
ESR(mm) 1r00 1r00 1r00 1r00 
PCV 45.12r3.28 44.16r3.12 43.56r3.22 42.12r3.24 
 
Values are mean r S.E.M. (Dunnet ’t' test). nsP>0.05; Vs Control N=6. 
 
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
Table-8.LipidProfile
 
Dose (mg/kg) Control 100 mg/kg 250 mg/kg 500 mg/kg 
Total cholesterol 
(mg/dL) 
40.20r2.45 41.10r2.26 42.14r3.45 42.10r3.18 
HDL(mg/dL) 14.28r2.30 14.20r1.72 14.00r1.55 14.29r2.21 
LDL(mg/dL) 43.12r2.45 44.41r3.10 43.62r3.39 43.21r3.24 
VLDL(mg/dl) 16.61r2.70 15.84r2.13 16.20r1.58 15.45r1.20 
Triglycerides (mg/dl) 85.80r3.02 85.32r2.78 86.41r3.04 85.34r2.26 
Blood glucose(mg/dl) 126.21r3.84 126.56r3.12 127.00r4.13 125.44r2.88 
 
Values are mean r S.E.M. (Dunnet ’t' test). nsP>0.05; Vs Control N=6. 
 
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
Table-9UrineAnalysis
Parameters Control 100 mg/kg 250 mg/kg 500 mg/kg 
Colour Yellow Yellow Yellow Yellow 
Transparency Clear Slightly turbid Slightly 
cloudy 
Slightly turbid 
Specific gravity 1.010 1.010 1.010 1.010 
PH >7.2 >8.0 >8.0 >9.0 
Protein Nil 3+ 3+ 3+ 
Glucose Nil Nil Nil Nil 
Bilirubin -ve -ve -ve -ve 
Ketones -ve +ve +ve +ve 
Blood Absent Absent Absent Absent 
Urobilinogen Normal Abnormal Abnormal Abnormal 
Pus cells 0-cells/HPF 1-cell/HPF 2-cells/HPF 1-cell/HPF 
RBCs Nil Nil 0-1cells/HPF Nil 
Epithelial cells Nil 1-cell/HPF Nil 1-cell/HPF 
Crystals Nil Nil Nil Nil 
Casts Nil Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen Bacteria seen 
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Table 10. Effect of oral administration of a Megarajanga  
Chooranam on organ weight 
Dose (mg/kg) Control 100 mg/kg 250 mg/kg 500 mg/kg 
Liver (g) 5.22r0.15 5.30r0.15 4.72r0.14 5.12r0.12 
Heart (g) 0.60r0.04 0.61r0.05 0.65r0.04 0.57r0.05 
Lung (g) 1.48r0.06 1.42r0.14 1.46r0.26 1.50r0.12 
Spleen (g) 0.69r0.06 0.69r0.04 0.69r0.05 0.65r0.04 
Ovary (g) 1.68r0.15 1.79r0.15 1.76r0.16 1.74r0.15 
Testes (g) 1.45r0.12 1.48r0.12 1.45r0.14 1.45r0.12 
Brain (g) 1.52r0.16 1.57r0.13 1.55r0.12 1.50r0.15 
Kidney (g) 0.72r0.04 0.70r0.04 0.72r0.05 0.71r0.04 
Stomach (g) 1.38r0.14 1.36r0.10 1.37r0.12 1.36r0.10 
 
Values are mean of 6 animals r S.E.M. (Dunnet's test). nsP>0.05; Vs Control N=6. 
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ANNEXURE - 4 
STATISTICAL  ANALYSIS OF CLINICAL STUDIES 
 
 All collected data were entered into ms excel software using different columns 
as variables and rows as patients. The probability value 0.05 was taken and as 
statistically significant level. Before and after treatment data was analyzed 
using paired ‘t’ test to determine the significance of treatment. The quantity 
variables were represented by means of mean + standard deviation and 
qualitative variables by means of percentage. Basic descriptive statistics 
include frequency distributions and cross tabulations. 
NO. OF CALCULI-RIGHT KIDNEY 
BT Mean S.D. T.Value Pvalue 
 1.516 + 0.889 5.4292 0.0000 
AT 0.677 + 0.747   
 
The average + standard deviation for Rt. Kidney calculi before and after 
treatment, were 1.5 + 0.889 & 0.6 + 0.747 respectively which is statistically 
highly significant (P<0.0001) 
NO. OF CALCULI-LEFT KIDNEY 
BT Mean S.D. T.Value Pvalue 
 1.548 + 0.994 4.2515 0.0001 
AT 0.709 + 0.782   
 
The average + standard deviation for Lt. Kidney calculi before and after 
treatment, were 1.54 + 0.994 & 0.70 + 0.782 respectively which is statistically 
highly significant (P<0.0001) 
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CALCULI MEASUREMENT - RIGHT KIDNEY 
BT Mean S.D. T.Value Pvalue 
 6.783 + 4.358 6.912 0.0000 
AT 2.5 + 2.883   
 
The average + standard deviation for Rt. Kidney calculi measurement before 
and after treatment, were 6.7 + 4.358 & 2.5 + 2.883 respectively which is 
statistically highly significant (P<0.0001) 
CALCULI MEASUREMENT - LEFT KIDNEY 
BT Mean S.D. T.Value Pvalue 
 7.10 + 5.106 6.1425 0.0000 
AT 0.90 + 3.512   
 
The average + standard deviation for Lt. Kidney calculi measurement before 
and after treatment, were 7.1 + 5.106 & 2.9 + 3.512 respectively which is 
statistically highly significant (P<0.0001) 
CLINICAL MANIFESTATIONS 
BT Mean S.D. T.Value Pvalue 
 2.95 + 1.108 12.83 0.0000 
AT 0.57 + 0.675   
 
The average + standard deviation for clinical manifestations before and after 
treatment, were 2.9 + 1.108 & 0.5 + 0.675 respectively which is statistically 
highly significant (P<0.0001) 
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ANNEXURE - 5 
CONSENT FORM 
 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient. 
 
DATE:   SIGNATURE 
 NAME: 
 
 
CONSENT BY THE PATIENT 
 
 
I have been informed to my satisfaction by the attending physician for 
the purpose of the clinical trial and the nature of the drug treatment and follow 
up including the lab investigation to be performed to monitor and safeguard my 
body functions. 
 
I am aware of my right to opt out of the trial at any time during the 
course of the trial without having to give reasons for doing so. 
 
 
I, exercising my free power of choice, hereby give my consent to be 
included as a subject in the clinical trial of MEGARAJANGA 
CHOORANAM for the treatment of KALLADAIPPU NOI. 
 
 
DATE: 
SIGNATURE NAME 
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§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø ÀÊÅõ 
 
 
           ¾¢Õ.____________________¬¸¢Â ¿¡ý ___________ÅÂÐ,         
(____________________________________________________
___________________________________________________ 
Åº¢ìÌõ þ¼õ.) ±ý ÍÂ ¿¢¨É×¼ý ±Ø¾¢ì ¦¸¡ÎìÌõ ´ôÒ¾ø ÀÊÅõ. 
   
          ¿¡ý PÀ»øh¨¦ ±ýÛõ §¿¡Â¡ø À¡¾¢ì¸ôÀðÎ ¦ºý¨É, «ÃÍ 
º¢ò¾ ÁÕòÐÅ ¸øæ¡¢Â¢ø (þ¼õ: «È¢b÷ «ñ½¡ þó¾¢Â 
ÁÕòÐÅÁ¨É, «ÕõÀ¡ì¸õ, ¦ºý¨É-106.) ¿¼ò¾ôÀÎõ º¢ò¾ 
ÁÕòÐÅ ¬Ã¡öîº¢ ãÄõ º¢¸¢î¨º ¦ÀÈ ±ý ÍÂ ¿¢¨É×¼ý 
ÓØºõÁ¾ò¨¾Ôõ ¦¾¡¢Å¢òÐì¦¸¡û¸¢§Èý. 
 
          þó¾ ¬Ã¡öîº¢Â¢ý §¿¡ì¸õ, ÁÕòÐÅõ ¦ºöÔõ Ó¨È, 
¦¾¡¼÷¸ñ¸¡½¢ôÒ  ÁüÚõ  ±ý  ¯¼ø  ¿Äõ  ÌÈ¢ò¾  ÁÕòÐÅ  
À¡¢§º¡¾¨É¸¨Çô ÀüÈ¢Â Å¢¡¢Å¡É Å¢Çì¸õ ±ÉìÌ ÁÕòÐÅõ ¦ºöÔõ 
ÁÕòÐÅ÷ ãÄõ ¦¾Ç¢×ÀÎò¾ôÀðÎûÇÐ. þó¾ ¬Ã¡öîº¢Â¢ø 
ÀíÌ¦¸¡ûÙõ ±ý ºõÁ¾ò¾¢üÌ Â¡Õ¨¼Â ¿¢÷Àó¾Óõ 
¸¡Ã½Á¢ø¨Ä±ýÀ¨¾ ¦¾¡¢Å¢òÐì¦¸¡û¸¢§Èý. 
 
 
þôÀÊìÌ, 
 
 
 
 
 
¦ÀÂ÷     : 
Ó¸Å¡¢  : 
 
¿¡û      : 
 
 
152 
 
ANNEXURE - 6 
OP/IP CASE SHEET PROFORMA 
POST GRADUATE DEPARTMENT, POTHU MARUTHUVAM 
(BRANCH-I) 
GOVT. SIDDHA MEDICAL COLLEGE & HOSPITAL, CHENNAI-106 
PROFORMA FOR ‘KALLADAIPU’ 
 
OP No./IP No. :  OCCUPATION : 
WARD NO. :  INCOME  : 
BED NO.  :  NATIONALITY : 
NAME : RELIGION : 
AGE  : D.O.A. : 
SEX  : D.O.D. : 
PERMANENT    DIAGNOSIS  : 
ADDRESS  :   
 
 
TEMPORARY ADDRESS: 
 
MEDICAL OFFICER 
 
COMPLAINTS AND DURATION 
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HISTORY OF PRESENT ILLNESS 
 
HISTORY OF PAST ILLNESS 
 
PERSONAL HISTORY: 
a.Food   veg/non-veg 
b.Marital Status single/married 
FAMILY HISTORY: 
 
GENERAL EXAMINATION : 
Physical built  : lean normal  obese 
Body weight  : 
Temperature : 
Pulse rate  : 
Heart rate  : 
Respiratory rate : 
Blood Pressure : 
Pallor   : 
Cyanosis  : 
Jaundice  : 
Clubbing  : 
Pedal Oedema : 
Lymph adenopathy: 
JVP  : 
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Examinations of vital organs: 
Heart   : 
Lungs   : 
Abdominal organs 
Palpation : renal angle 
  Tenderness Present/Absent 
SIDDHA ASPECTS 
Yakkai (udalnilai)      Mukkunam 
1.  Vatham     1.Sathuva Gunam 
2.Pitham     2.Raasatha Gunam 
3.Kapham     3.Thamo Gunam 
4.Kalapu 
Paruva Kaalam (seasons)     Nilam (Places) 
1.Kaar Kaalam (Aavani-Puratasi)  1.Kurinchi (Hill area) 
2.Koothir Kaalam (Aypasi-Karthigai) 2.Mullai (Forest area) 
3.Munpani Kaalam (Maargazhi-Thai) 3.Marutham (Fertile area) 
4.Pinpani Kaalam (Maasi-Panguni)  4.Neithal (Sea area) 
5.Elavenil Kaalam (Chithirai-Vaikasi) 5.Paalai (Desert area) 
6.Mudhuvenil Kaalam (Aani-Aadi)   
Iyamporigal/Pulangal   Kanmenthiriyam/Kanmavidayam 
1.Mei (Sensation)    1.Kai (Koduthal) 
2.Vaai (Taste)     2.Kaal (Nadathal) 
3.Kann (Vision)    3.Vaai (Pesal) 
4.Mooku (Smell)    4.Eruvaai (Kazhithal) 
5.Sevi (Hearing)    5.Karuvaai (Aananthithal) 
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Mummalam 
1. Malam 
2. Moothiram 
3. Viyarvai 
Uyir Thathukkal: 
Vaatham 
1. Pranan     6.Naagan   
2. Abanan   7.Koorman 
3. Viyanan     8.Kirukaran 
4. Udhanan     9.Devadathan 
5. Samanan   10. Dhananjayan 
Pitham   Kapham 
1. Analagam 1. Avalambagam 
2. Ranjagam 2. Kledagam 
3. Saadhagam 3. Podhagam 
4. Aalosagam 4. Tharpagam 
5. Prasagam 5. Santhigam 
Udal Thathukkal 
1. Saaram 
2. Senneer 
3. Oon 
4. Kozhuppu 
5. Enbu 
6. Moolai 
7. Sukkilam / Suronitham 
Envagai Thervu 
1. Naa 
2. Niram 
3. Mozhi 
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4. Vizhi 
5. Sparisam 
6. Malam 
  a) Niram 
   b) Nurai 
   c) Erugal 
   d) Elagal 
7. Moothiram 
1. Neerkuri   
 a) Niram 
   b) Edai 
   c) Manam 
   d) Nurai 
   e) Enjal 
2. Neikuri 
8. Naadi 
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SIGNS AND SYMPTOMS OF KALLADAIPU 
Assessment Before 
Treatment 
After Treatment 
10th 
day 
20th 
day 
30th 
day 
40th 
day 
1. Pain 
9 Site 
9 Radiation 
9 Character 
     
2. Nausea      
3. Vomiting      
4. Burning Micturition      
5. Dysuria      
6. Oliguria      
7. Haematuria      
8. Retention      
9. Fever      
10. Frequency of Micturition      
 
 
  
158 
 
LABORATORY INVESTIGATIONS 
BT                                                              AT 
1.   Blooc  Tc 
   Dc 
   ESR 
   Hb 
   B1-Sugar ® 
   B1-Urea 
   Sr. Cholesterol 
   Sr. Creatinine 
2.   Urine 
  Colour 
  Turbidity 
  Alb 
  Sug 
  Dep 
x Epethelial cells 
x RBC’s 
x Pus Cells 
  Casts  
  Specific gravity 
  Urine culture and sensitivity if necessary 
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3. X-Ray  KUB 
4. USG  Abdomen & Pelvis 
 TRIAL DRUGS 
 Dose: 
 Anubanam: 
 Duration of treatment: 
 Pathiam (Do’s and Don’ts): 
 Prognosis at the end of the treatment 
 
 
 Medical Officer Signature     H.O.D. 
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